{
  "meta": {
    "title": "Biochemistry_Subject_Test_1_Bioenergetics_Enzymes_Vitamins_Nutrients",
    "url": "https://brainandscalpel.vercel.app/biochemistry-subject-test-1-bioenergetics-enzymes-vitamins-nutrients-43c2f22c.html",
    "scrapedAt": "2025-11-30T11:10:40.013Z"
  },
  "questions": [
    {
      "id": 1,
      "choices": [
        {
          "id": 1,
          "text": "<p><span style=\"font-size:12.0pt;\">Isoniazid therapy</span></p>"
        },
        {
          "id": 2,
          "text": "<p><span style=\"font-size:12.0pt;\">Congenital defect in the intestinal and renal transport of neutral amino acids</span></p>"
        },
        {
          "id": 3,
          "text": "<p><span style=\"font-size:12.0pt;\">Carcinoid syndrome</span></p>"
        },
        {
          "id": 4,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystinuria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man presents with recurrent loose stools, irritability, and memory lapses. On examination, there are bilaterally symmetric, rough, pigmented, scaling lesions on the dorsum of his hands and around his neck in a collar-like distribution. His relatives report personality changes over the last few weeks. Which of the following conditions cannot lead to the clinical syndrome seen in this patient?</span></p>",
      "unique_key": "Q319458",
      "question_audio": null,
      "question_video": null,
      "map_id": 319458,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong> </p><p>Among the given options, <strong>cystinuria</strong> does <strong>not</strong> lead to <strong>pellagra,</strong> which is being described in the question stem.</p><ul><li>Niacin refers to nicotinic acid and nicotinamide, both of which are biologically active.</li><li>Its major role is as the nicotinamide ring of the coenzymes <strong>NAD</strong> and <strong>NADP</strong>, which participate in numerous oxidation-reduction reactions, DNA repair, and calcium mobilisation.</li><li>The body can obtain niacin either directly from food or by converting <strong>tryptophan </strong>to niacin <strong>(&asymp; 60 mg tryptophan = 1 mg niacin equivalent).</strong></li><li>Conversion of tryptophan to niacin requires riboflavin, <strong>pyridoxine</strong>, and iron.</li><li>Bioavailability: High from animal products (milk, meat, eggs), low from cereals unless enriched with free niacin.</li><li>Excess niacin (&ge; 500 mg/day) may cause flushing, skin irritation, and liver damage. </li></ul><p><strong>Pellagra</strong> </p><ul><li>Pellagra arises from the deficiency of niacin or tryptophan.</li><li>Characterized by the triad of dermatitis, diarrhea, and dementia, which can progress to death if untreated.</li><li>The dermatitis is photosensitivity with <strong>hyperpigmented, scaling lesions</strong> (e.g., Casal's necklace around the neck).<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/1E.png\"></li><li>Other features include <strong>glossitis</strong>, vaginitis, esophagitis, abdominal pain, depression, seizures, and psychosis.</li><li>Pellagra is preventable and treatable with niacin or nicotinamide supplementation (100-200 mg three times daily). </li></ul><p><strong>Causes of Pellagra</strong> </p><ol><li><strong>Dietary deficiency:</strong> Seen in populations relying heavily on corn/maize, which is low in bioavailable niacin and tryptophan.</li><li><strong>Genetic/metabolic causes:</strong><ul><li><strong>Hartnup disease </strong>&#8594; defect in intestinal and renal transport of tryptophan and other neutral amino acids &#8594; reduced niacin synthesis. <strong>(Option B ruled out)</strong></li><li><strong>Carcinoid syndrome </strong>&#8594; tryptophan shunted toward serotonin production, reducing its availability for niacin synthesis. <strong>(Option C ruled out)</strong></li></ul></li><li><strong>Drug-related: Isoniazid (structural analogue of niacin)</strong> can interfere with niacin metabolism and precipitate pellagra.<strong> (Option A ruled out)</strong></li><li><strong>Micronutrient deficiencies:</strong> Lack of riboflavin, vitamin B6, or iron impairs tryptophan-to-niacin conversion.</li><li><strong>Alcoholism and malnutrition:</strong> Common settings for pellagra in developed regions.</li></ol>",
      "correct_choice_id": 4,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 2,
      "choices": [
        {
          "id": 11,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxylation of proline and lysine residues during collagen synthesis</span></p>"
        },
        {
          "id": 12,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxylation of proline and leucine residues during collagen synthesis</span></p>"
        },
        {
          "id": 13,
          "text": "<p><span style=\"font-size:12.0pt;\">Cross-linking of collagen fibres due to ATP7A mutation</span></p>"
        },
        {
          "id": 14,
          "text": "<p><span style=\"font-size:12.0pt;\">Cross-linking of collagen fibres due to defective lysyl oxidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy is brought with swollen, bleeding gums, irritability, and painful legs. On examination, there are subperiosteal hemorrhages and tenderness of long bones. His diet consists mainly of cow's milk with very little fruit or vegetables. Which of the following enzymatic reactions is primarily impaired in this condition?</span></p>",
      "unique_key": "Q319459",
      "question_audio": null,
      "question_video": null,
      "map_id": 319459,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The given clinical scenario is consistent with a diagnosis of <strong>scurvy</strong> in which <strong>hydroxylation of proline and lysine residues during collagen synthesis</strong> is impaired.</p><ul><li>Vitamin C (ascorbic acid and dehydroascorbic acid) is biologically active in humans, primates, guinea pigs, bats, and certain birds, because they lack <strong>gulonolactone oxidase </strong>needed for endogenous synthesis.</li><li>Acts as a <strong>reducing agent and antioxidant</strong>, promoting <strong>nonheme iron absorption</strong>, collagen formation, catecholamine biosynthesis, carnitine production, and metabolism of peptide hormones.</li><li>Functions also include roles in DNA/histone demethylation and in mixed-function oxidase enzyme systems.</li></ul><p><strong>Enzymatic Roles of Vitamin C</strong></p><p><strong>Cofactor for hydroxylases:</strong></p><ul><li><strong>Proline and lysine hydroxylases </strong>&#8594; stabilize collagen during its conversion from procollagen. <strong>(Option B ruled out) </strong></li><li>Dopamine &beta;-hydroxylase &#8594; converts dopamine to norepinephrine.</li><li>Peptidylglycine hydroxylase &#8594; modifies peptide hormones at their glycine termini.</li><li>Enzymes for<strong> carnitine synthesis</strong> (trimethyllysine and &gamma;-butyrobetaine hydroxylases).</li><li>Required for reducing oxidized iron and copper during enzymatic reactions.</li></ul><p><strong>Deficiency - Scurvy</strong></p><ul><li>Occurs mainly in the poor, elderly, alcoholics with poor diets, and individuals with restricted or <strong>unbalanced intake</strong>.</li><li>Symptoms reflect<strong> impaired collagen synthesis</strong> and catecholamine metabolism.</li><li>Skin changes, fragile blood vessels, petechiae, <strong>perifollicular hemorrhage</strong>.</li><li>Bleeding gums, tooth loss, bone pain or fractures.</li><li>Fatigue, irritability, psychological changes.</li><li>Bleeding may extend to joints, peritoneum, pericardium, and adrenal glands.</li><li>In children: impaired bone growth.</li><li>Diagnosis: low plasma or leukocyte Vitamin C levels.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Impaired cross-linking of collagen due to ATP7A mutation (Option C): </strong>Describes <strong>Menke's disease</strong>.</p><p><strong>Defective cross-linking of collagen due to defective lysyl oxidase (Option D): </strong>Consistent with <strong>Menke's disease</strong>.</p>",
      "correct_choice_id": 11,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 3,
      "choices": [
        {
          "id": 21,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkaline phosphatase</span></p>"
        },
        {
          "id": 22,
          "text": "<p><span style=\"font-size:12.0pt;\">Carbonic anhydrase</span></p>"
        },
        {
          "id": 23,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboxypeptidase A</span></p>"
        },
        {
          "id": 24,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy presents with chronic diarrhea, poor wound healing, growth retardation, and scaly periorificial dermatitis. His hair is sparse, and he shows delayed puberty. Which of the following enzyme function is least likely to be defective in this boy?</span></p>",
      "unique_key": "Q319460",
      "question_audio": null,
      "question_video": null,
      "map_id": 319460,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong> </p><p>The most likely diagnosis based on the clinical scenario is acrodermatitis enteropathica which arises due to <strong>zinc deficiency</strong>, and among the given options, the enzyme not dependent on zinc is<strong> pyruvate dehydrogenase</strong>. </p><ul><li><strong>Zinc </strong>is an essential trace element, present in many <strong>metalloenzymes</strong> and structural proteins.</li><li>It contributes to the <strong>synthesis and stabilization </strong>of proteins, DNA, and RNA, and plays a key role in ribosome and membrane structure.</li><li>Necessary for steroid hormone receptor binding and other transcription factor interactions with DNA.</li><li>Critical for spermatogenesis, fetal growth, and embryonic development.</li><li>The human body contains thousands of zinc-containing proteins, including zinc finger transcription factors, which stabilize DNA- and RNA-binding domains. </li></ul><p><strong>Enzymes Requiring Zinc</strong> </p><p>Zinc acts as a cofactor for several enzymes such as:</p><ul><li>Alkaline phosphatase <strong>(Option A ruled out)</strong></li><li>Carbonic anhydrase <strong>(Option B ruled out)</strong></li><li>Carboxypeptidase A <strong>(Option C ruled out) </strong></li><li>Alcohol dehydrogenase</li><li>Superoxide dismutase (cytosolic form)</li><li>Phospholipase C, adenosine deaminase, and leucine aminopeptidase </li></ul><p><strong>Absorption and Inhibitors</strong> </p><ul><li>Zinc is absorbed in the intestine</li><li>Absorption is reduced by phytates, fiber, oxalates, iron, and copper, as well as by drugs like penicillamine, sodium valproate, and ethambutol.</li><li>Bioavailability is higher in animal proteins (meat, shellfish, nuts, legumes) compared to grains and legumes, as phytates in cereals bind zinc and limit absorption. </li></ul><p><strong>Zinc Deficiency - Causes</strong> </p><ul><li>Can arise in malabsorption syndromes, chronic illnesses (diabetes, HIV/AIDS, cirrhosis, sickle cell disease, IBD), alcoholism, and with drugs like penicillamine.</li><li>Acrodermatitis enteropathica: a rare <strong>autosomal recessive</strong> condition causing <strong>impaired zinc absorption</strong>. </li></ul><p><strong>Clinical Features of Zinc Deficiency</strong> </p><ul><li><strong>Mild deficiency:</strong> growth retardation, impaired taste (hypogeusia), decreased immunity.</li><li><strong>Severe deficiency:</strong> <strong>hypogonadism</strong>, dwarfism, hypopigmented hair, depression, irritability.</li><li><strong>Skin and mucosal signs:</strong> vesicular and pustular rash around extremities, face, and perineum; scaling and erythema.<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/3E.png\"></li><li><strong>Other features: alopecia</strong>, <strong>chronic diarrhea</strong>, poor wound healing, muscle wasting, depression, stunted growth, and immune dysfunction.</li></ul>",
      "correct_choice_id": 24,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 4,
      "choices": [
        {
          "id": 31,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired hydroxylation of proline and lysine residues during collagen synthesis</span></p>"
        },
        {
          "id": 32,
          "text": "<p><span style=\"font-size:12.0pt;\">Defective antioxidant protection of neuronal membranes and red blood cells against free radical damage</span></p>"
        },
        {
          "id": 33,
          "text": "<p><span style=\"font-size:12.0pt;\">Inability to carry out &gamma;-carboxylation of glutamate residues in clotting factors</span></p>"
        },
        {
          "id": 34,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired function of thymidylate synthase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old boy presents with features of fat malabsorption. On examination, he has loss of vibration and position sense, ataxia, and decreased reflexes. He also has mild hemolytic anemia. Which of the following best explains the underlying mechanism of these symptoms?</span></p>",
      "unique_key": "Q319461",
      "question_audio": null,
      "question_video": null,
      "map_id": 319461,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong> </p><p>The most likely underlying mechanism in this clinical scenario is <strong>defective antioxidant protection of neuronal membranes and red blood cells against free radical damage </strong>due to <strong>vitamin E deficiency</strong>. </p><ul><li><strong>Vitamin E </strong>is the collective name for tocopherols and tocotrienols, with &alpha;-tocopherol being the most biologically important for humans.</li><li>It is a<strong> lipid-soluble antioxidant </strong>that protects cell membranes and plasma lipoproteins from oxidative damage by neutralizing lipid peroxide radicals.</li><li>Functions also include maintaining <strong>membrane stability</strong>, influencing cell signaling, and modulating the activities of certain enzymes.</li><li>Exists in different natural and synthetic forms, but only the natural d-&alpha;-tocopherol is most potent biologically. </li></ul><p><strong>Mechanism of Action</strong> </p><ul><li>Acts as a<strong> chain-breaking antioxidant:</strong> captures free radicals in membranes and lipoproteins, especially polyunsaturated fatty acids.</li><li>The intermediate tocopheroxyl radical is relatively stable and can be recycled back to tocopherol by Vitamin C.</li><li>This antioxidant network (Vitamin E + Vitamin C + glutathione) maintains Vitamin E in its active, reduced state. </li></ul><p><strong>Absorption and Metabolism</strong> </p><ul><li>Absorbed with dietary fat and packaged in chylomicrons, then delivered to the liver.</li><li>Transported in plasma via &alpha;-tocopherol transfer protein, which inserts Vitamin E into very-low-density lipoproteins (VLDL).</li><li>The RDA for Vitamin E in adults is about 15 mg/day.</li><li>It is abundant in vegetable oils (sunflower, safflower, wheat germ oil), nuts, meats, and small amounts in fruits and vegetables.</li><li>Higher intake may be required in diets rich in polyunsaturated fats. </li></ul><p><strong>Vitamin E Deficiency causes</strong> </p><ul><li><strong>Severe fat malabsorption</strong> (e.g., celiac disease, <strong>cystic fibrosis</strong>, chronic liver disease, prolonged cholestasis).</li><li>Genetic defect in <strong>&alpha;-tocopherol transfer protein.</strong></li><li>Abetalipoproteinemia &#8594; impaired absorption and transport of Vitamin E.</li><li>Premature infants (inadequate stores at birth). </li></ul><p><strong>Clinical manifestations of vitamin E deficiency:</strong> </p><ul><li><strong>Neurological:</strong> degeneration of large myelinated axons &#8594;<strong> posterior column</strong> and spinocerebellar tract involvement &#8594; ataxia, areflexia, loss of vibration and position sense, peripheral neuropathy.</li><li><strong>Ocular and muscular:</strong> ophthalmoplegia, skeletal myopathy, pigmentary retinopathy.</li><li><strong>Hematologic:</strong> <strong>hemolytic anemia</strong> due to fragile RBC membranes from lipid peroxidation. </li></ul><p><strong>Explanations of other options:</strong></p><p><strong>Impaired hydroxylation of proline and lysine residues during collagen synthesis (Option A): </strong>Suggestive of vitamin C deficiency.</p><p><strong>Inability to carry out &gamma;-carboxylation of glutamate residues in clotting factors (Option C): </strong>Consistent with vitamin K deficiency.</p><p><strong>Impaired function of thymidylate synthase (Option D): </strong>Seen in folic acid deficiency which causes megaloblastic anemia and no neurological symptoms.</p>",
      "correct_choice_id": 32,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 5,
      "choices": [
        {
          "id": 41,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxylation of proline residues during collagen formation</span></p>"
        },
        {
          "id": 42,
          "text": "<p><span style=\"font-size:12.0pt;\">Decarboxylation of glutamate to &gamma;-aminobutyric acid</span></p>"
        },
        {
          "id": 43,
          "text": "<p><span style=\"font-size:12.0pt;\">&gamma;-carboxylation of glutamate residues in clotting factors</span></p>"
        },
        {
          "id": 44,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduction of ribonucleotides to deoxyribonucleotides by ribonucleotide reductase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man undergoing treatment for pulmonary tuberculosis develops progressive irritability, painful tingling in his hands and feet, and recurrent seizures. On examination, he has peripheral neuropathy and pallor. Bone marrow examination reveals the following finding. Which of the following enzyme reactions is most directly impaired in this patient's condition?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/5Q.png\"></span></p>",
      "unique_key": "Q319462",
      "question_audio": null,
      "question_video": null,
      "map_id": 319462,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong> </p><p>The most likely underlying etiology causing peripheral neuropathy, recurrent seizures, pallor and ringed sideroblasts on bone marrow examination in a patient on isoniazid is <strong>Vitamin B6 deficiency</strong> which leads to impaired <strong>decarboxylation of glutamate to &gamma;-aminobutyric acid</strong> </p><p><strong>Vitamin B6</strong> </p><ul><li>Refers to a group of compounds: pyridoxine, pyridoxal, and pyridoxamine, along with their 5&prime;-phosphate derivatives.</li><li>The active form is pyridoxal 5&prime;-phosphate (PLP), a coenzyme for over 100 enzymes.</li><li>About 80% of body stores are in muscle, bound to glycogen phosphorylase.</li></ul><p><strong>Functions</strong></p><ul><li><strong>Amino acid metabolism:</strong><ul><li>Transamination, decarboxylation, and transsulfuration reactions</li><li>Conversion of tryptophan &#8594; niacin.</li><li>Homocysteine &#8594; cystathionine.</li><li>Heme synthesis: cofactor for &delta;-aminolevulinate synthase (first step).</li><li>Glycogen metabolism: PLP binds to glycogen phosphorylase.</li><li>Neurotransmitter synthesis: required for GABA, serotonin, dopamine, norepinephrine.</li><li>Steroid hormone action: PLP regulates interaction of hormone-receptor complexes with DNA.</li></ul></li></ul><p><strong>Deficiency</strong> </p><ul><li><strong>Causes:</strong> rare in healthy individuals; may occur in alcoholics, malabsorption, infants, or with <strong>drugs</strong> (isoniazid, hydralazine, penicillamine, cycloserine, L-dopa).</li><li><strong>Pyridoxine </strong>is given along with isoniazid to prevent neuropathy.</li></ul><p><strong>Features:</strong> </p><ul><li>Neurological: <strong>peripheral neuropathy</strong>, irritability,<strong> seizures</strong>, abnormal EEG.</li><li>Hematological: <strong>microcytic hypochromic (sideroblastic) anemia </strong>(&#8595; heme synthesis).</li><li>Dermatological: epithelial changes, glossitis.</li><li>Psychiatric: depression, confusion.</li><li>Infants: diarrhea, seizures, anemia.</li></ul><p><strong>Diagnosis</strong> </p><ul><li>Based on low plasma PLP (&lt;20 nmol/L).</li><li>Functional test: <strong>erythrocyte transaminase activity </strong>&#8593; when PLP added in vitro.</li></ul><p><strong>Explanation of other options:</strong> </p><p><strong>Hydroxylation of proline residues during collagen formation (Option A): </strong>This is consistent with<strong> Vitamin C deficiency</strong>. </p><p><strong>&gamma;-carboxylation of glutamate residues in clotting factors (Option C): </strong>This is seen in<strong> Vitamin K deficiency</strong>.</p><p> </p><p><strong>Reduction of ribonucleotides to deoxyribonucleotides by ribonucleotide reductase (Option D): </strong>Ribonucleotide reductase is a metalloenzyme containing<strong> iron</strong>.</p>",
      "correct_choice_id": 42,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 6,
      "choices": [
        {
          "id": 51,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythrocyte transaminase activity</span></p>"
        },
        {
          "id": 52,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythrocyte transketolase activity</span></p>"
        },
        {
          "id": 53,
          "text": "<p><span style=\"font-size:12.0pt;\">Ames assay</span></p>"
        },
        {
          "id": 54,
          "text": "<p><span style=\"font-size:12.0pt;\">Erythrocyte glutathione reductase activity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 48-year-old chronic alcoholic presents with confusion, unsteady gait, and abnormal eye movements. His diet has been poor, and he often skips meals. Which of the following enzyme activities is considered a functional assay of the most likely deficient vitamin?</span></p>",
      "unique_key": "Q319463",
      "question_audio": null,
      "question_video": null,
      "map_id": 319463,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong> </p><p>The most likely deficient vitamin this patient who is a chronic alcoholic who has presented with confusion, ataxia, and abnormal eye movements is<strong> vitamin B1 (thiamine) </strong>and its functional status can be assessed using<strong> erythrocyte transketolase activity</strong>. </p><p><strong>Vitamin B1 (Thiamine)</strong> </p><ul><li><strong>Active form:</strong> Thiamine diphosphate (TPP), a coenzyme for <strong>oxidative decarboxylation</strong> of &alpha;-ketoacids and branched-chain amino acids.</li><li>Key enzyme complexes requiring TPP:<ul><li><strong>Pyruvate dehydrogenase</strong> (links glycolysis to TCA cycle).</li><li><strong>&alpha;-ketoglutarate dehydrogenase</strong> (TCA cycle).</li><li><strong>Branched-chain ketoacid dehydrogenase</strong> (leucine, isoleucine, valine metabolism).</li><li><strong>Transketolase </strong>(pentose phosphate pathway)</li></ul></li><li>Thiamine triphosphate may also regulate nerve function by activating chloride channels.</li></ul><p><strong>Food Sources</strong> </p><ul><li>Rich in yeast, organ meat, pork, legumes, beef, whole grains, and nuts.</li><li>Low in <strong>milled rice</strong> and processed grains &#8594; major cause of deficiency where polished rice is staple.</li><li>Destroyed by cooking, heat, and food processing.</li><li>Antithiamine factors: <strong>thiaminases</strong> (raw fish, shellfish) and polyhydroxyphenols (tea, coffee, betel nut, Brussels sprouts).</li></ul><p><strong>Clinical syndromes associated with deficiency:</strong> </p><ul><li><strong>Dry beriberi </strong>&#8594; symmetric peripheral neuropathy of motor and sensory nerves, diminished reflexes</li><li><strong>Wet beriberi </strong>&#8594; high-output cardiac failure, tachycardia, edema, cardiomegaly.</li><li><strong>Shoshin beriberi </strong>&#8594; acute, fulminant heart failure with metabolic acidosis.</li><li><strong>Wernicke's encephalopathy </strong>&#8594; nystagmus, ophthalmoplegia, ataxia, confusion.</li><li><strong>Wernicke-Korsakoff syndrome</strong> &#8594; Wernicke features plus memory loss and confabulation.</li><li><strong>Biochemical consequence: </strong>impaired conversion of pyruvate to acetyl-CoA &#8594; buildup of pyruvate/lactate &#8594;<strong> lactic acidosis</strong> (especially with high-carb intake). </li></ul><p><strong>Diagnosis</strong> </p><ul><li>Best test: <strong>Erythrocyte transketolase </strong>activity before and after thiamine pyrophosphate addition.</li><li>&gt; 25% increase = deficiency (activity coefficient &gt;1.25).</li><li>Thiamine or phosphorylated esters can also be measured directly by HPLC.</li></ul><p><strong>Explanation of other options:</strong> </p><p><strong>Erythrocyte transaminase activity (Option A): Vitamin B6 status</strong> is assessed by estimating <strong>erythrocyte transaminase activity</strong>. </p><p><strong>Ames assay (Option C): </strong>The Ames assay uses a specially engineered strain of Salmonella typhimurium to identify mutagenic compounds. Since many carcinogens act as mutagens, detection of mutagenicity through this assay suggests possible carcinogenic potential. </p><p><strong>Erythrocyte glutathione reductase activity (Option D): </strong>It is used to assess riboflavin (Vitamin B2) activity.</p>",
      "correct_choice_id": 52,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 7,
      "choices": [
        {
          "id": 61,
          "text": "<p><span style=\"font-size:12.0pt;\">0.7</span></p>"
        },
        {
          "id": 62,
          "text": "<p><span style=\"font-size:12.0pt;\">0.8</span></p>"
        },
        {
          "id": 63,
          "text": "<p><span style=\"font-size:12.0pt;\">0.85</span></p>"
        },
        {
          "id": 64,
          "text": "<p><span style=\"font-size:12.0pt;\">1.0</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 27-year-old woman has been on a strict ketogenic diet for 3 months, consisting primarily of fats with minimal carbohydrates. She reports fatigue during exercise but denies any respiratory symptoms. Indirect calorimetry is performed to evaluate her metabolic fuel utilization. Her respiratory quotient (RQ) is found to be close to the typical value seen with predominant fat metabolism. What is the expected RQ value in this patient?</span></p>",
      "unique_key": "Q319464",
      "question_audio": null,
      "question_video": null,
      "map_id": 319464,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The expected respiratory quotient in this patient on a diet primary consisting of fats is<strong> 0.7.</strong></p><p><strong>Respiratory Quotient (RQ) and Metabolic States</strong></p><ul><li>After a meal (fed state), caloric intake exceeds immediate energy needs. Excess calories are stored as glycogen and lipid.</li><li>Oxidation of substrates consumes oxygen and produces carbon dioxide. The ratio of CO&#8322; produced to O&#8322; consumed is called the respiratory quotient (RQ).</li></ul><p><strong>RQ values for different fuels:</strong></p><ul><li>Carbohydrates &#8594; 1.0 <strong>(Option D ruled out) </strong></li><li>Proteins &#8594; 0.81<strong> (Option B ruled out)</strong></li><li>Fats &#8594; 0.71</li><li>Alcohol &#8594; 0.66</li></ul><p><strong>Fed state </strong>(especially after a carbohydrate-rich meal):</p><ul><li>Carbohydrate oxidation predominates.</li><li>RQ approaches 1.0.</li><li>Over a 24-hour period on a<strong> mixed diet</strong>, average RQ is around 0.85, reflecting the combined oxidation of carbohydrates, fats, and proteins. <strong>(Option C ruled out)</strong></li><li>In fasting, carbohydrate oxidation decreases, <strong>fat oxidation increases</strong>, and RQ shifts downward toward 0.7.</li><li>Storage of excess calories as glycogen and fat requires energy, contributing to the <strong>thermic effect</strong> of food, which accounts for about<strong> 10% of daily energy expenditure</strong>.</li></ul>",
      "correct_choice_id": 61,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 8,
      "choices": [
        {
          "id": 71,
          "text": "<p><span style=\"font-size:12.0pt;\">Impaired function of alcohol dehydrogenase</span></p>"
        },
        {
          "id": 72,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenosis</span></p>"
        },
        {
          "id": 73,
          "text": "<p><span style=\"font-size:12.0pt;\">Kashin-Beck disease</span></p>"
        },
        {
          "id": 74,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkali disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 19-year-old male from China presents with progressive fatigue, palpitations, and shortness of breath on exertion. Examination shows tachycardia and features of cardiomyopathy. Laboratory evaluation rules out viral myocarditis and ischemic disease. He is diagnosed with Keshan disease. Which of the following is another manifestation that might be seen in this patient?</span></p>",
      "unique_key": "Q319465",
      "question_audio": null,
      "question_video": null,
      "map_id": 319465,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The likely manifestation that might be seen in this patient diagnosed with Keshan disease, which arises secondary to<strong> selenium deficiency</strong>, is <strong>Kashin-Beck disease</strong>.</p><ul><li><strong>Selenium</strong>, in the form of selenocysteine, is a key component of enzymes such as <strong>glutathione peroxidase</strong>, which protects proteins, membranes, lipids, and nucleic acids by breaking down hydrogen peroxide and lipid hydroperoxides.</li><li>This prevents oxidative damage to hemoglobin and cell structures. It is also required for <strong>deiodinase enzymes</strong>, which convert thyroxine (T4) into the active hormone triiodothyronine (T3).</li><li>Dietary selenium is mainly obtained from seafood, meat, and cereals, although its content in crops depends on <strong>soil concentration</strong>.</li></ul><p><strong>Deficiency</strong></p><ul><li><strong>Keshan disease:</strong> An <strong>endemic cardiomyopathy</strong> seen in selenium-deficient areas of China, particularly in children and young women.</li><li><strong>Kashin-Beck disease:</strong> An <strong>osteoarticular disorder</strong> with epiphyseal damage and deforming arthropathy, linked to selenium and iodine deficiency, which worsens oxidative stress in chondrocytes. Kashin-Beck disease shows a characteristic geographical pattern, mainly affecting farming areas in eastern Siberia, northern Korea, and <strong>central China</strong>.</li><li>Low selenium also aggravates cretinism when combined with iodine deficiency.</li></ul><p><strong>Toxicity</strong></p><ul><li>Chronic excess intake leads to <strong>selenosis</strong>, marked by hair and nail brittleness, loss, skin rash, irritability, neurological abnormalities, and a<strong> garlic-like odor</strong> to the breath.<strong> (Option B ruled out)</strong></li><li>Historically, in livestock, high-selenium forages caused <strong>alkali disease</strong> in the American Great Plains. <strong>(Option D ruled out) </strong></li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Impaired function of alcohol dehydrogenease (Option A): </strong>It is a metalloenzyme containing <strong>zinc.</strong></p><p><strong>Reference:</strong></p><p><a title=\"https://pubmed.ncbi.nlm.nih.gov/38757132/ \" href=\"https://pubmed.ncbi.nlm.nih.gov/38757132/%20\" target=\"_blank\">https://pubmed.ncbi.nlm.nih.gov/38757132/</a></p><p><a title=\"https://www.ncbi.nlm.nih.gov/books/NBK216723/ \" href=\"https://www.ncbi.nlm.nih.gov/books/NBK216723/%20\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK216723/</a></p><p><a href=\"https://pmc.ncbi.nlm.nih.gov/articles/PMC3080494/\" target=\"_blank\">https://pmc.ncbi.nlm.nih.gov/articles/PMC3080494/</a></p>",
      "correct_choice_id": 73,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 9,
      "choices": [
        {
          "id": 81,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper</span></p>"
        },
        {
          "id": 82,
          "text": "<p><span style=\"font-size:12.0pt;\">Cobalt</span></p>"
        },
        {
          "id": 83,
          "text": "<p><span style=\"font-size:12.0pt;\">Manganese</span></p>"
        },
        {
          "id": 84,
          "text": "<p><span style=\"font-size:12.0pt;\">Molybdenum</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 3-month-old infant presents with recurrent seizures, developmental delay, and progressive neurological deterioration. Urine analysis reveals high levels of sulfite, and further studies demonstrate deficiency of sulfite oxidase. Deficiency of which trace metal is most likely responsible for this condition?</span></p>",
      "unique_key": "Q319466",
      "question_audio": null,
      "question_video": null,
      "map_id": 319466,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Sulfite oxidase</strong> is an iron and <strong>molybdenum</strong> containing metalloenzyme.</p><p><strong>Molybdenum</strong></p><p>Molybdenum is a key part of the universal cofactor molybdopterin, acting as a catalytic prosthetic group in several oxidase enzymes:</p><ul><li>Xanthine oxidase (hypoxanthine &rarr; xanthine &rarr; uric acid)</li><li>Aldehyde oxidase (broad substrate detoxification, similar to cytochrome P450 system)</li><li><strong>Sulfite oxidase</strong> (sulfite &rarr; sulfate)</li></ul><p><strong>Catalytic function:</strong></p><ul><li>The metal cycles between +4, +5, and +6 oxidation states, enabling transfer of electrons in these enzyme reactions.</li><li>Sulfite oxidase, for instance, uses <strong>Fe-Mo metalloenzyme activity</strong> to move electrons via <strong>cytochrome c</strong>.</li></ul><p><strong>Deficiency:</strong></p><ul><li>Caused by mutations in MOCS1, MOCS2, or GPHN genes, leading to defective <strong>molybdopterin</strong></li><li>Results in sulfite oxidase deficiency, where<strong> sulfur-containing amino acids</strong> (cysteine, methionine) cannot be metabolized.</li><li>This leads to accumulation of toxic derivatives in neonates, causing severe deformities, <strong>brain damage</strong>, intractable seizures, profound developmental delay, and early death.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Copper (Option A): </strong>Copper is a vital cofactor for nearly 30 human metalloenzymes, such as cytochrome oxidase, <strong>dopamine &beta;-hydroxylase</strong>, tyrosinase, the cytosolic Cu-Zn superoxide dismutase, and lysyl oxidase. It is not a component of sulfite oxidase.</p><p><strong>Cobalt (Option B): </strong>The main function of dietary cobalt is as the central atom in <strong>5&prime;-deoxyadenosylcobalamin (vitamin B<sub>12</sub>). </strong>Within this cofactor, cobalt in the +3 oxidation state is positioned in a <strong>corrin ring</strong>, where it facilitates the transfer of one-carbon groups such as methyl or methylene. In humans, this is crucial for the transfer of a<strong> methyl group </strong>from tetrahydrofolate to homocysteine to form methionine, as well as for the conversion of methylmalonyl-CoA to succinyl-CoA during the breakdown of propionate derived from isoleucine and <strong>odd-chain fatty acids</strong>.</p><p><strong>Manganese (Option C): </strong>Manganese is required for only a limited number of enzymes in humans, most of which are located in the mitochondria. These include<strong> isocitrate dehydrogenase </strong>of the TCA cycle, glutamate synthetase and arginase involved in nitrogen metabolism, and the gluconeogenic enzymes pyruvate carboxylase and phosphoenolpyruvate carboxykinase, along with isopropyl malate synthase and mitochondrial superoxide dismutase (Mn-SOD).</p>",
      "correct_choice_id": 84,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 10,
      "choices": [
        {
          "id": 91,
          "text": "<p><span style=\"font-size:12.0pt;\">Flushing, itching, and hyperglycemia</span></p>"
        },
        {
          "id": 92,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe sensory neuropathy</span></p>"
        },
        {
          "id": 93,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased intracranial pressure with headache</span></p>"
        },
        {
          "id": 94,
          "text": "<p><span style=\"font-size:12.0pt;\">Burning feet syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old girl from a rural village presents with progressive difficulty seeing at night. On physical examination, the following finding is noted. If this child were instead to consume excess amounts of the vitamin which is deficient, which of the following clinical features would most likely develop?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/10Q.png\"></span></p>",
      "unique_key": "Q319467",
      "question_audio": null,
      "question_video": null,
      "map_id": 319467,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The vitamin deficient in this child with difficulty seeing at night and examination revealing phrynoderma is vitamin A and in excess, it can cause <strong>Increased intracranial pressure with headache.</strong></p><ul><li><strong>Vitamin A</strong> refers to retinol and retinyl esters, with metabolites like retinaldehyde and retinoic acid also biologically active.</li><li><strong>Retinal (11-cis)</strong> is vital for vision, while retinoic acid regulates cell growth, differentiation, and gene expression through retinoid receptors (RARs, RXRs).</li><li>The vitamin exists as preformed retinyl esters and provitamin A carotenoids (mainly &beta;-carotene) in the diet.</li><li>The liver stores about 90% of body reserves and releases vitamin A bound to <strong>retinol-binding protein,</strong> ensuring safe transport and uptake. Retinoids also influence immunity, iron utilization, and cell-mediated defenses.</li></ul><p><strong>Deficiency</strong></p><ul><li><strong>Vitamin A deficiency</strong> is a major cause of preventable blindness globally. Early signs include reduced sensitivity to green light, progressing to night blindness, and later xerophthalmia with corneal keratinization, which can cause blindness.</li><li>Clinical features include <strong>Bitot's spots,</strong> conjunctival dryness, and keratomalacia.</li><li>Deficiency also impairs immune responses, increasing vulnerability to infections, especially in children, and contributes to higher mortality rates in undernourished populations and during pregnancy.</li><li>Cutaneous manifestations include xerosis, scaling, dermomalacia and phrynoderma.</li><li><strong>Phrynoderma </strong>which presents as rough, keratotic follicular papules that typically affect the anterolateral thighs and posterolateral upper arms but may also spread to the extensor areas of the limbs, shoulders, back, posterior neck, and abdomen, giving a \"<strong>toad-like\" appearance</strong>.</li><li>While often linked to vitamin A deficiency, it is not specific to it and can also occur with deficiencies of B-complex vitamins, vitamin C, vitamin E, essential fatty acids, and even zinc.</li></ul><p><strong>Toxicity</strong></p><ul><li>Excess vitamin A overwhelms binding proteins, leading to free vitamin A-induced tissue damage.</li><li>Acute toxicity manifests with<strong> increased intracranial pressure</strong>, nausea,<strong> headache</strong>, vertigo, seizures, and exfoliative dermatitis, which may be fatal.</li><li>Chronic toxicity presents with <strong>dry skin</strong>, alopecia, cheilosis, hepatomegaly, hyperlipidemia, <strong>hypercalcemia</strong>, bone pain, amenorrhea, pseudotumor cerebri, and liver fibrosis.</li><li>In pregnancy, excess vitamin A or retinoid exposure can cause teratogenic effects such as<strong> craniofacial </strong>and cardiac malformations.</li><li>High-dose &beta;-carotene is generally non-toxic but may cause <strong>carotenemia</strong> (yellowing of skin) and has been linked to adverse effects in smokers<strong>.</strong></li></ul><p><strong>Explanations of other options:</strong></p><p><strong>Flushing, itching, and hyperglycemia (Option A): </strong>Describes features seen in niacin toxicity.</p><p><strong>Severe sensory neuropathy (Option B): </strong>Seen in Vitamin B6 toxicity. Peripheral neuropathy is also seen in vitamin B6 deficiency.</p><p><strong>Burning feet syndrome (Option D): </strong>Associated with <strong>pantothenic acid (Vitamin B5) deficiency.</strong></p>",
      "correct_choice_id": 93,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 11,
      "choices": [
        {
          "id": 101,
          "text": "<p><span style=\"font-size:12.0pt;\">Arises due to mutation in ATP7A gene</span></p>"
        },
        {
          "id": 102,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper deficiency impairs cytochrome c oxidase and dopamine &beta;-hydroxylase activity</span></p>"
        },
        {
          "id": 103,
          "text": "<p><span style=\"font-size:12.0pt;\">Copper histidine therapy may be beneficial if started early</span></p>"
        },
        {
          "id": 104,
          "text": "<p><span style=\"font-size:12.0pt;\">Deficiency of copper prevents proper functioning of lysyl hydroxylase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-month-old male infant presents with developmental delay, seizures, and recurrent episodes of hypothermia. His parents report that his hair has become sparse, brittle, depigmented, and twisted as shown. Examination shows hypotonia, failure to thrive, and hypopigmented skin. Laboratory investigations reveal low serum copper and ceruloplasmin. Which of the following statements regarding the underlying defect in this condition is incorrect?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/11Q.png\"></span></p>",
      "unique_key": "Q319468",
      "question_audio": null,
      "question_video": null,
      "map_id": 319468,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The most likely diagnosis based on the clinical features of developmental delay, seizures, and recurrent episodes of hypothermia along with depigmented hair, along with low serum copper and ceruloplasmin is <strong>Menkes disease</strong>, in which deficiency of copper prevents proper functioning of<strong> lysyl oxidase</strong>, causing defective collagen cross-linking.</p><ul><li><strong>Menkes disease</strong>, also called <strong>kinky hair disease</strong>, is an <strong>X-linked recessive </strong>neurodegenerative disorder caused by mutations in the <strong>ATP7A gene</strong>, which encodes a copper-transporting ATPase.<strong> (Option A ruled out)</strong></li><li>The defect leads to <strong>impaired intestinal absorption</strong> and transport of copper, resulting in <strong>low serum copper and ceruloplasmin</strong>.</li><li>The shortage of copper disrupts the function of multiple copper-dependent enzymes such as superoxide dismutase, <strong>cytochrome c oxidase</strong>, and <strong>dopamine &beta;-hydroxylase</strong>. <strong>(Option B ruled out) </strong></li><li>Symptoms appear within the first months of life and include hypothermia, <strong>hypotonia</strong>, seizures, and distinctive facial features with chubby cheeks and<strong> brittle, kinky, depigmented hair</strong>.</li><li>Hair microscopy often reveals trichorrhexis nodosa and pili torti.</li><li>Affected children also experience feeding difficulties, severe developmental delay, vascular tortuosity, and optic atrophy.</li><li>Neuropathological changes include degeneration of cerebral gray matter and Purkinje cell loss in the cerebellum.</li><li>Without treatment, death typically occurs by age three. Rarely, females may present with milder disease.</li><li><strong>Copper histidine </strong>injections may slow neurological decline if <strong>started very early</strong>, especially in infants with residual copper transport activity.<strong> (Option C ruled out) </strong></li><li>The clinical manifestations also stem from <strong>deficient lysyl oxidase</strong>, a copper-dependent enzyme essential for collagen cross-linking.</li></ul>",
      "correct_choice_id": 104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 12,
      "choices": [
        {
          "id": 111,
          "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune &beta;-cell destruction with absolute insulin deficiency</span></p>"
        },
        {
          "id": 112,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced cellular response to insulin at muscle and adipose tissue</span></p>"
        },
        {
          "id": 113,
          "text": "<p><span style=\"font-size:12.0pt;\">Inherited LDL receptor defect causing impaired cholesterol clearance</span></p>"
        },
        {
          "id": 114,
          "text": "<p><span style=\"font-size:12.0pt;\">Mutation in glucokinase gene impairing hepatic glucose sensing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old woman with marked central obesity has come for a routine checkup. On examination, the following finding is seen. Her blood tests reveal fasting glucose of 118 mg/dL, triglycerides of 210 mg/dL, and HDL of 32 mg/dL. Blood pressure is 148/92 mmHg. Which of the following best explains the underlying mechanism for this patient's condition?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/12Q.png\"></span></p>",
      "unique_key": "Q319469",
      "question_audio": null,
      "question_video": null,
      "map_id": 319469,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The most likely diagnosis based on the laboratory parameters and the finding of acanthosis nigricans is metabolic syndrome which arises due to <strong>reduced cellular response to insulin at muscle and adipose tissue.</strong></p><ul><li><strong>Metabolic syndrome</strong> is a cluster of metabolic abnormalities that heightens the risk of cardiovascular disease and type 2 diabetes.</li><li>It is characterized by <strong>central obesity</strong>, <strong>elevated triglycerides</strong>, <strong>reduced HDL cholesterol</strong>, hyperglycemia, and hypertension.</li></ul><p><strong>Risk Factors</strong></p><ul><li><strong>Overweight/Obesity</strong> - A strong driver, with visceral fat central to insulin resistance.</li><li><strong>Sedentary Lifestyle </strong>- Physical inactivity worsens adiposity, dyslipidemia, hypertension, and hyperglycemia. <strong>Prolonged screen time</strong> (&gt;4 h/day) doubles the risk.</li><li><strong>Genetics</strong> - Multiple variants contribute; heritability of traits exceeds 50%.</li><li><strong>Aging</strong> - Nearly half of U.S. adults &gt;60 years are affected, with <strong>women</strong> more commonly impacted.</li></ul><p><strong>Associated Conditions</strong></p><ul><li><strong>Diabetes Mellitus</strong> - ~75% of patients with type 2 diabetes or impaired glucose tolerance have metabolic syndrome.</li><li><strong>Cardiovascular Disease (CVD)</strong> - Patients are twice as likely to die from CVD; risk of heart disease and stroke is markedly higher.</li><li><strong>Lipodystrophy</strong> - Both genetic and acquired forms are strongly linked to insulin resistance and metabolic syndrome.</li></ul><p><strong>Etiology &amp; Pathophysiology</strong></p><ul><li><strong>Central Role of Insulin Resistance</strong> - Impaired insulin action leads to hyperinsulinemia and hyperglycemia.</li><li><strong>Fatty Acids</strong> - Excess circulating free fatty acids from adipose tissue drive insulin resistance, impair glucose uptake, and promote lipid accumulation in liver and muscle.</li><li>Leptin Resistance - Reduced leptin action worsens appetite control and insulin sensitivity.</li><li><strong>Adipokines &amp; Inflammation </strong>- Dysregulated adipokines (adiponectin &darr;, resistin &uarr;, TNF-&alpha; &uarr;) promote systemic insulin resistance and vascular dysfunction.</li><li><strong>Gut Microbiome</strong> - Altered bacterial composition may contribute to metabolic dysfunction.</li></ul><p><strong>Metabolic Abnormalities</strong></p><ul><li><strong>Waist Circumference </strong>- Strong marker of risk, though precise measurement methods vary.</li><li><strong>Glucose Intolerance</strong> - Impaired suppression of hepatic glucose output, progressing to type 2 diabetes.</li><li><strong>Hypertension</strong> - Related to insulin resistance, sodium retention, and vascular dysfunction.</li><li><strong>Dyslipidemia </strong>- Elevated triglycerides and low HDL levels increase atherosclerotic risk.</li><li><strong>Proinflammatory Cytokines </strong>- IL-6, TNF-&alpha;, and others amplify systemic inflammation.</li></ul><p><strong>Clinical Features</strong></p><ul><li>Common associations include <strong>acanthosis nigricans</strong>, fatty liver disease, polycystic ovary syndrome (PCOS), <strong>obstructive sleep apnea (OSA)</strong>, and hyperuricemia.</li><li>Strong links to <strong>atherosclerosis</strong>, myocardial infarction, stroke, and Alzheimer's disease.</li></ul><p><strong>Explanations of other options:</strong></p><p><strong>Autoimmune &beta;-cell destruction with absolute insulin deficiency (Option A): </strong>Describes<strong> type 1 Diabetes Mellitus</strong>. The presence of dyslipidemia, hypertension, and central obesity is more suggestive of metabolic syndrome.</p><p><strong>Inherited LDL receptor defect causing impaired cholesterol clearance (Option C): </strong>Explains pathogenesis of <strong>familial hypercholesterolemia </strong>which usually presents with elevated LDL and normal triglyceride levels.</p><p><strong>Mutation in glucokinase gene (Option D): </strong>Leads to<strong> MODY</strong> (Maturity onset diabetes of young)</p>",
      "correct_choice_id": 112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 13,
      "choices": [
        {
          "id": 121,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate carboxylase</span></p>"
        },
        {
          "id": 122,
          "text": "<p><span style=\"font-size:12.0pt;\">Succinate dehydrogenase</span></p>"
        },
        {
          "id": 123,
          "text": "<p><span style=\"font-size:12.0pt;\">Methylmalonyl-CoA mutase</span></p>"
        },
        {
          "id": 124,
          "text": "<p><span style=\"font-size:12.0pt;\">Transketolase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old man presents with painful cracks at the corners of his mouth, a magenta-colored tongue, and burning, itchy eyes with photophobia. On examination, the following findings are noted. His diet mainly consists of polished rice, with little milk or green vegetables. Which of the following enzymes will be most directly impaired in this patient?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/13Q.png\"></span></p>",
      "unique_key": "Q319470",
      "question_audio": null,
      "question_video": null,
      "map_id": 319470,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The most likely deficient vitamin in this patient is <strong>riboflavin (Vitamin B2)</strong> which is required for the enzyme <strong>succinate dehydrogenase</strong>.</p><ul> <li><strong>Riboflavin (vitamin B<sub>2</sub>)</strong> is an essential nutrient that functions as a coenzyme in energy metabolism, primarily in the form of flavin mononucleotide (FMN) and flavin adenine dinucleotide (FAD).</li><li>These cofactors participate in numerous oxidation-reduction reactions, including those in the<strong> tricarboxylic acid (TCA) cycle</strong>, fatty acid and amino acid oxidation, and the mitochondrial respiratory chain.</li><li>Enzymes that require riboflavin, known as flavoenzymes, include<strong> succinate dehydrogenase</strong>, monoamine oxidase, and glutathione reductase.</li><li>FAD also plays a role in regulating homocysteine metabolism through methylenetetrahydrofolate reductase and is important in <strong>drug and steroid metabolism</strong>.</li><li>Riboflavin deficiency, though uncommon, is usually due to<strong> inadequate dietary intake</strong>.</li><li>Clinical signs include inflammation and lesions of the lips and tongue (cheilosis, glossitis), <strong>seborrheic dermatitis</strong>, corneal vascularization, and sometimes anemia and mood changes.</li><li>Laboratory diagnosis is typically made by assessing <strong>erythrocyte glutathione reductase</strong> activity with and without added FAD.</li><li>Riboflavin deficiency is rarely fatal because the body conserves it efficiently and can recycle it from degraded enzymes.</li><li>Major dietary sources include<strong> milk, dairy products</strong>, enriched cereals, meats, eggs, legumes, and <strong>green vegetables</strong>.</li><li>Riboflavin is highly light-sensitive, so proper storage of foods like milk is important to prevent its loss. Notably, riboflavin has no established toxicity, as excess is excreted in the urine.</li></ul><p><strong>Explanations of other options:</strong></p><p><strong>Pyruvate carboxylase (Option A): </strong>The coenzyme for pyruvate carboxylase is <strong>biotin</strong>.</p><p><strong>Methylmalonyl-CoA mutase (Option C): Vitamin B12 </strong>acts as the coenzyme for methylmalonyl-CoA mutase</p><p><strong>Transketolase (Option D): </strong>The active form of<strong> Vitamin B1</strong> functions as the coenzyme for transketolase.</p>",
      "correct_choice_id": 122,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 14,
      "choices": [
        {
          "id": 131,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxylation of lysine residues in collagen fibrils</span></p>"
        },
        {
          "id": 132,
          "text": "<p><span style=\"font-size:12.0pt;\">&gamma;-carboxylation of glutamate residues in bone matrix proteins</span></p>"
        },
        {
          "id": 133,
          "text": "<p><span style=\"font-size:12.0pt;\">Activation of alkaline phosphatase in osteoblasts</span></p>"
        },
        {
          "id": 134,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of 25-hydroxy vitamin D to calcitriol in the kidney</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 68-year-old woman with atrial fibrillation is on long-term warfarin therapy. She presents with diffuse bone pain and a recent low-impact vertebral fracture. Her coagulation profile shows prolonged PT/INR, consistent with the effect of her medication. Bone biopsy reveals impaired calcium binding by osteocalcin, despite normal dietary calcium intake and vitamin D status. Which of the following biochemical processes is most likely inhibited in this patient due to her treatment?</span></p>",
      "unique_key": "Q319471",
      "question_audio": null,
      "question_video": null,
      "map_id": 319471,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The likely biochemical process inhibited in this patient on warfarin therapy is <strong>&gamma;-carboxylation of glutamate residues in bone matrix proteins </strong>due to inhibition of Vitamin K.</p><p><strong>Role of Vitamin K</strong></p><ul><li>Essential for the synthesis of blood-clotting proteins 2, 7, 9, 10</li><li>Antagonists like dicumarol and <strong>warfarin</strong> are used therapeutically to reduce coagulation.</li></ul><p><strong>Forms of Vitamin K</strong></p><ul><li>Phylloquinone - primary dietary form from green vegetables</li><li>Menaquinones - produced by intestinal bacteria.</li><li>Menadione and derivatives - synthetic forms convertible to phylloquinone.</li></ul><p><strong>Biochemical Function</strong></p><ul><li>Acts as a coenzyme for <strong>carboxylation of glutamate residues</strong> in proteins, producing <strong>&gamma;-carboxyglutamate (GLA).</strong></li><li>This modification allows <strong>proteins to bind calcium</strong> and anchor to membranes.</li><li>The process involves a cycle: hydroquinone &rarr; epoxide &rarr; quinone &rarr; hydroquinone, regulated by warfarin-sensitive reductases.</li><li>High doses of vitamin K can counteract warfarin overdose.</li></ul><p><strong>Targets of Vitamin K Action</strong></p><ul><li><strong>Clotting factors:</strong> Prothrombin (II), VII, IX, X, and proteins C &amp; S. These contain multiple GLA residues essential for calcium binding and function.</li><li><strong>Bone and tissue proteins:</strong> <strong>Osteocalcin</strong>, matrix Gla protein, nephrocalcin, and Gas6-important in bone strength, vascular biology, nervous system regulation, and apoptosis.</li></ul><p><strong>Deficiency</strong></p><ul><li>Leads to impaired synthesis of vitamin K-dependent proteins in blood, bone, lung, kidney, and placenta.</li><li>Common causes: reduced intake, malabsorption, <strong>broad-spectrum antibiotic</strong>s, chronic liver disease, or bile salt deficiency.</li><li>In newborns, deficiency can cause <strong>hemorrhagic disease</strong>; prevented by routine neonatal vitamin K administration.</li><li>Laboratory clue: <strong>prolonged prothrombin time (PT)</strong> is an early indicator.</li></ul><p><strong>Management</strong></p><ul><li>Mild deficiency: treated with low doses of vitamin K (oral or IV).</li><li>Severe deficiency/anticoagulant reversal: higher doses, <strong>fresh frozen plasma (FFP)</strong>, or prothrombin complex concentrates (PCC).</li><li>Vitamin K administration must be balanced in patients requiring anticoagulation to prevent thromboembolic risk.</li></ul><p><strong>Explanation of other options:</strong></p><ul><li><strong>Hydroxylation of lysine residues in collagen fibrils (Option A): Incorrect.</strong> This is a <strong>vitamin C-dependent</strong> step in collagen maturation, not affected by warfarin.</li><li><strong>Activation of alkaline phosphatase in osteoblasts (Option C): Incorrect.</strong> ALP activity relates to matrix mineralization and phosphate handling; it is <strong>not vitamin K-dependent</strong>.</li><li><strong>Conversion of 25-hydroxy vitamin D to calcitriol (Option D): Incorrect.</strong> This renal 1&alpha;-hydroxylation depends on <strong>PTH</strong> and kidney function, <strong>not</strong> on vitamin K/warfarin.</li></ul>",
      "correct_choice_id": 132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 15,
      "choices": [
        {
          "id": 141,
          "text": "<p><span style=\"font-size:12.0pt;\">Folic acid deficiency</span></p>"
        },
        {
          "id": 142,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin B12 deficiency</span></p>"
        },
        {
          "id": 143,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron deficiency anemia</span></p>"
        },
        {
          "id": 144,
          "text": "<p><span style=\"font-size:12.0pt;\">Vitamin C deficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 36-year-old man presents with fatigue, glossitis, and tingling in his feet. He follows a strict vegan diet. Examination shows pallor and impaired vibration sense in the lower limbs. Blood tests reveal:<br>Hemoglobin: 8.9 g/dL<br>MCV: 112 fL<br>Peripheral smear: hypersegmented neutrophils<br>Serum homocysteine: &uarr; elevated<br>Serum methylmalonic acid: &uarr; elevated<br>Which of the following is the most likely diagnosis?</span></p>",
      "unique_key": "Q319472",
      "question_audio": null,
      "question_video": null,
      "map_id": 319472,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The most likely diagnosis in this patient with a strict vegan diet, glossitis, <strong>neurological symptoms</strong>, hypersegmented neutrophils on peripheral smear, and elevated homocysteine and <strong>methylmalonic acid</strong> is <strong>vitamin B12 deficiency</strong>.</p><p>Cobalamin (Vitamin B12) has a cobalt atom within a corrin ring. Exists in several forms:</p><ul><li>Adenosylcobalamin (mitochondrial, cofactor for methylmalonyl-CoA mutase).</li><li>Methylcobalamin (cytoplasmic, cofactor for methionine synthase).</li><li>Hydroxocobalamin (present in small amounts; rapidly interconverted).</li></ul><p><strong>Sources &amp; Requirements</strong></p><ul><li>Synthesized only by <strong>microorganisms</strong>.</li><li>Humans obtain it mainly from animal products (meat, fish, dairy).</li><li><strong>Plant foods lack cobalamin</strong> unless contaminated by bacteria.</li></ul><p><strong>Absorption</strong></p><p><strong>Two pathways:</strong></p><p><strong>1. Passive</strong> - throughout intestine, inefficient (&lt;1%).</p><p><strong>2. Active </strong>- in ileum, requires <strong>intrinsic factor (IF).</strong></p><ul><li>Dietary B12 is released from food proteins by gastric enzymes and binds <strong>haptocorrins </strong>(HCs).</li><li>In intestine, HCs are degraded, and cobalamin transfers to IF, secreted by gastric <strong>parietal cells</strong>.</li><li>The IF-B12 complex binds <strong>cubilin</strong> receptors in the ileum for absorption.</li><li>Absorbed B12 enters blood bound to transcobalamin II (TC II).</li><li><strong>Enterohepatic circulation</strong> helps maintain levels; deficiency develops faster in malabsorption than in vegans.</li></ul><p><strong>Clinical Features of Deficiency</strong></p><ul><li><strong>General:</strong> Anemia, anorexia, weight loss, diarrhea/constipation.</li><li><strong>Oral:</strong> Glossitis, angular cheilosis.</li><li><strong>Severe cases:</strong> Jaundice, fever, hyperpigmentation.</li><li><strong>Hematology:</strong> Macrocytosis, <strong>megaloblastic anemia</strong>, thrombocytopenia, leukopenia.</li><li><strong>Neurological: </strong>Peripheral neuropathy, cognitive changes, impaired proprioception, psychiatric symptoms.</li><li><strong>Infections:</strong> Increased susceptibility (respiratory, urinary).</li></ul><p><strong>Hematologic Findings</strong></p><ul><li><strong>Peripheral blood:</strong> Macrocytic anemia with anisocytosis, poikilocytosis, hypersegmented neutrophils.</li><li><strong>Bone marrow:</strong> Hypercellular, megaloblastic changes, increased early erythroid precursors, possible myelodysplasia-like appearance.</li></ul><p><strong>Causes of Deficiency</strong></p><p><strong>1. Inadequate intake: Seen in strict vegans or severe malnutrition.</strong></p><p><strong>2. Malabsorption:</strong></p><ul><li><strong>Gastric causes: </strong>Pernicious anemia (autoimmune IF deficiency), gastrectomy, congenital IF defects.</li><li><strong>Intestinal causes:</strong> Ileal resection, Crohn's, tropical sprue, fish tapeworm, celiac disease, HIV infection, radiation injury.</li><li><strong>Pancreatic disease:</strong> Failure to release cobalamin from HC.</li><li><strong>Genetic defects:</strong> Cubilin/TC II abnormalities.</li></ul><p><strong>3. Abnormal metabolism</strong></p><ul><li>Congenital methylmalonic acidemia/acidemia.</li><li>Nitrous oxide toxicity (inactivates methylcobalamin).</li></ul><p><strong>4. Pernicious Anemia (PA): </strong>Common autoimmune cause of severe deficiency, especially in older adults of Northern European descent.</p><p><strong>Diagnosis:</strong></p><ul><li>Both serum methylmalonic acid and homocysteine levels are elevated in vitamin B12 deficiency.</li><li>Serum cobalamin levels can be measured using ELIZA</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Folic acid deficiency (Option A): </strong>Serum homocysteine levels are elevated but not methylmalonic acid. There are no neurological symptoms.</p><p><strong>Iron deficiency anemia (Option C): </strong>Peripheral smear shows microcytic hypochromic anemia. Homocysteine and methylmalonic acid levels are not elevated.</p><p><strong>Vitamin C deficiency (Option D): </strong>Leads to clinical features like inflamed and bleeding gums, perifollicular hemorrhages, and poor wound healing.</p>",
      "correct_choice_id": 142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 16,
      "choices": [
        {
          "id": 151,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzymes lower the activation energy by stabilizing the transition state</span></p>"
        },
        {
          "id": 152,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzymes increase the equilibrium constant (Keq) by favoring product formation</span></p>"
        },
        {
          "id": 153,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzymes accelerate the rate at which equilibrium is reached</span></p>"
        },
        {
          "id": 154,
          "text": "<p><span style=\"font-size:12.0pt;\">Enzymes do not alter the overall Gibbs free energy (&Delta;G) of a reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man is being treated with a novel antiviral drug that acts by inhibiting a viral protease. The drug mimics the transition state of the normal substrate, binding the enzyme tightly and preventing catalysis. Which of the following statements about enzyme action is false?</span></p>",
      "unique_key": "Q319473",
      "question_audio": null,
      "question_video": null,
      "map_id": 319473,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Enzymes<strong> do not change </strong>the equilibrium constant (Keq).</p><p><strong>Biomedical Importance of Enzyme Kinetics</strong> </p><ul><li>Enzymes regulate essential biochemical processes, and balanced activity is required for homeostasis.</li><li><strong>Enzyme kinetics</strong> measures <strong>how fast enzyme-catalyzed reactions occur</strong> and what factors influence them.</li><li>Clinical uses include diagnosing disease through abnormal enzyme levels (e.g., in myocardial infarction, prostate cancer, or liver injury).</li><li>Because enzymes are central to nearly all physiological pathways, they are also key drug targets.</li></ul><p><strong>Chemical Reactions and Equilibrium</strong></p><ul><li>Reactions are described using balanced equations, showing substrates and products in correct proportions.</li><li>Reversibility is a fundamental property of chemical reactions; many reactions in cells are functionally irreversible because products are quickly removed.</li><li>The <strong>Gibbs</strong> <strong>free energy change (&Delta;G) </strong>determines whether a reaction proceeds forward or backward.</li><li>Negative &Delta;G &rarr; reaction is spontaneous.</li><li>Positive &Delta;G &rarr; unfavorable unless coupled with other processes.</li></ul><p><strong>Rates of Reactions</strong></p><ul><li>Reaction speed depends on the <strong>activation energy barrier (&Delta;G&Dagger;)</strong> that must be overcome to form a transition state.</li><li>The <strong>transition state</strong> is a <strong>high-energy intermediate</strong> between reactants and products.</li><li>The rate of reaction increases when more molecules have sufficient kinetic energy to reach this state.</li><li>The free energy, activation energy, and transition state are shown with an example in the image below. </li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/16E.png\"><p><strong>Factors affecting rate:</strong></p><ul><li><strong>Temperature: </strong>increases kinetic energy and collision frequency.</li><li><strong>Concentration:</strong> higher concentrations increase collision probability.</li><li><strong>Collision theory: </strong>molecules must collide with proper orientation and energy.</li></ul><p><strong>Reaction Orders and Rate Constants</strong></p><ul><li>The rate law describes how reaction rate depends on concentrations of reactants.</li><li>Reactions can be first-order, second-order, or higher, depending on <strong>how many molecules</strong></li><li>The rate constant (k) is characteristic of a given reaction under set conditions.</li><li>At equilibrium, the ratio of forward and backward rate constants equals the <strong>equilibrium constant (Keq).</strong></li></ul><p><strong>Enzyme Catalysis</strong> </p><ul><li>Enzymes <strong>lower activation energy</strong> by <strong>stabilizing the transition state,</strong> not by altering &Delta;G of the overall reaction. <strong>(Options A and D ruled out) </strong></li><li>Mechanisms include:<ul><li>Acid-base catalysis (proton transfer)</li><li>Electrostatic stabilization by charged groups or metals</li><li>Steric effects that position substrates properly.</li><li>Some enzymes use covalent catalysis, where a temporary covalent bond forms with the substrate. </li></ul></li></ul><p>Note: <strong>HIV protease</strong> stabilizes transition states; serine proteases like chymotrypsin form covalent intermediates.</p><p><strong>Enzymes and Equilibrium</strong></p><ul><li>Enzymes do not affect equilibrium constants (Keq)</li><li>They <strong>accelerate</strong> how<strong> quickly equilibrium is reached </strong>by<strong> lowering &Delta;G&Dagger;,</strong> but the final ratio of substrates to products is unchanged.<strong> (Option C ruled out) </strong></li><li>This is because<strong> Keq depends only on the free energy of initial and final states</strong>, not on the catalytic pathway.</li></ul>",
      "correct_choice_id": 152,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 17,
      "choices": [
        {
          "id": 161,
          "text": "<p><span style=\"font-size:12.0pt;\">Succinate dehydrogenase - Biotin</span></p>"
        },
        {
          "id": 162,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyruvate dehydrogenase - Thiamine pyrophosphate (TPP)</span></p>"
        },
        {
          "id": 163,
          "text": "<p><span style=\"font-size:12.0pt;\">Lactate dehydrogenase - Pyridoxal phosphate (PLP)</span></p>"
        },
        {
          "id": 164,
          "text": "<p><span style=\"font-size:12.0pt;\">Glutamate dehydrogenase - Vitamin C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following enzyme-cofactor pairs is correctly matched?</span></p>",
      "unique_key": "Q319474",
      "question_audio": null,
      "question_video": null,
      "map_id": 319474,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Among the given options, the correctly matched enzyme-cofactor pair is <strong>pyruvate dehydrogenase - Thiamine pyrophosphate (TPP). </strong></p><p><strong>Pyruvate Oxidation: Link Between Glycolysis and the Citric Acid Cycle</strong></p><ul><li><strong>Pyruvate</strong>, formed in glycolysis, is transported into mitochondria via a symporter.</li><li>It undergoes <strong>irreversible oxidative decarboxylation</strong> to form <strong>acetyl-CoA</strong>, catalyzed by the pyruvate dehydrogenase complex (PDH complex).</li><li>This multi-enzyme system is analogous to the &alpha;-ketoglutarate dehydrogenase complex and is located near the inner mitochondrial membrane.</li></ul><p><strong>Structure and Function of the PDH Complex</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/17E.png\"><ul><li>The reaction begins with pyruvate being decarboxylated by the <strong>pyruvate dehydrogenase (E1) enzyme</strong>, producing a hydroxyethyl intermediate bound to <strong>thiamine pyrophosphate (TPP)</strong>.</li><li>This intermediate is transferred to <strong>dihydrolipoyl transacetylase (E2),</strong> where it reacts with lipoamide to generate acetyl-lipoamide.<strong> Coenzyme A </strong>then forms acetyl-CoA from this intermediate.</li><li><strong>Dihydrolipoyl dehydrogenase (E3)</strong> reoxidizes reduced lipoamide using<strong> FAD</strong>, which is in turn reoxidized by <strong>NAD&#8314;</strong>, producing NADH.</li></ul><p>The overall reaction is:</p><p>Pyruvate + NAD&#8314; + CoA &#8594; Acetyl-CoA + NADH + H&#8314; + CO&#8322;</p><ul><li>The complex keeps intermediates channeled between enzymes, enhancing efficiency and preventing side reactions.</li></ul><p><strong>Regulation of PDH</strong></p><ul><li><strong>End-product inhibition:</strong> Acetyl-CoA and NADH inhibit the enzyme.</li><li>Covalent modification: <strong>Phosphorylation</strong> by a specific kinase (stimulated by high ATP, NADH, or acetyl-CoA) inactivates PDH.</li><li><strong>Dephosphorylation </strong>by a phosphatase (stimulated by ADP, pyruvate, and insulin) activates it.</li><li>PDH activity is reduced in energy-rich states and increased during fasting or when fatty acids are oxidized, ensuring balanced energy metabolism.</li></ul><p><strong>Clinical Aspects</strong></p><ul><li><strong>Lactic acidosis </strong>occurs when PDH is inhibited, leading to pyruvate buildup and its conversion to lactate.</li><li><strong>Inhibitors:</strong> <strong>Arsenic</strong> and mercury ions block the -SH groups of lipoic acid, preventing normal function.</li><li><strong>Thiamine (vitamin B&#8321;)</strong> deficiency impairs PDH activity and can cause severe lactic acidosis; this is common in <strong>alcoholism </strong>due to poor diet and reduced thiamine absorption.</li><li>Inherited PDH deficiency (mutations in PDH complex enzymes) leads to lactic acidosis, especially after glucose intake, and often causes neurological problems since the brain depends heavily on glucose metabolism.</li></ul><p><strong>Explanation of other options: </strong></p><p><strong>Succinate dehydrogenase - Biotin (Option A): </strong>Succinate dehyrogenase uses <strong>FAD</strong>, not biotin.</p><p><strong>Lactate dehydrogenase - Pyridoxal phosphate (PLP) (Option C): </strong>Lactate dehydrogenase used NADH as a cofactor.</p><p><strong>Glutamate dehydrogenase - Vitamin C (Option D): </strong>Glutamate dehydrogenase can use either NAD+ or NADP+.</p>",
      "correct_choice_id": 162,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 18,
      "choices": [
        {
          "id": 171,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 172,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 173,
          "text": "<p><span style=\"font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 174,
          "text": "<p><span style=\"font-size:12.0pt;\">8</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 42-year-old man with poorly controlled type 1 diabetes presents with nausea, vomiting, and Kussmaul breathing. His labs show:<br><br>1. Blood glucose: 58 mg/dL<br>2. Ketone bodies: markedly elevated<br>3. Arterial blood gas: metabolic acidosis<br><br>In the fasting state, his liver attempts to restore blood glucose by gluconeogenesis. How many molecules of ATP and GTP together are required to synthesize one molecule of glucose from two molecules of pyruvate via gluconeogenesis?</span></p>",
      "unique_key": "Q319475",
      "question_audio": null,
      "question_video": null,
      "map_id": 319475,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><ul><li><strong>Stepwise requirement</strong>:<ul><li>Pyruvate &rarr; Oxaloacetate (pyruvate carboxylase) &rarr; <strong>2 ATP</strong></li><li>Oxaloacetate &rarr; PEP (PEP carboxykinase) &rarr; <strong>2 GTP</strong></li><li>3-phosphoglycerate &rarr; 1,3-bisphosphoglycerate (3-PG kinase) &rarr; <strong>2 ATP</strong></li></ul></li><li><strong>Total = 4 ATP + 2 GTP = 6 high-energy bonds</strong></li></ul><p>This energy demand is why gluconeogenesis is suppressed unless absolutely required (e.g., fasting, DKA, starvation).</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/18E.png\">",
      "correct_choice_id": 173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19,
      "choices": [
        {
          "id": 181,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases the maximum velocity (Vmax) of alcohol dehydrogenase</span></p>"
        },
        {
          "id": 182,
          "text": "<p><span style=\"font-size:12.0pt;\">It competitively inhibits alcohol dehydrogenase, preventing methanol metabolism</span></p>"
        },
        {
          "id": 183,
          "text": "<p><span style=\"font-size:12.0pt;\">It irreversibly binds alcohol dehydrogenase, leading to enzyme inactivation</span></p>"
        },
        {
          "id": 184,
          "text": "<p><span style=\"font-size:12.0pt;\">It activates aldehyde dehydrogenase to accelerate methanol clearance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man is brought to the emergency department after consuming homemade alcohol. He is confused and has severe abdominal pain and visual disturbances. He is suspected of methanol poisoning and is started on intravenous ethanol therapy. Which of the following best explains the mechanism by which ethanol acts as an antidote in this condition?</span></p>",
      "unique_key": "Q319476",
      "question_audio": null,
      "question_video": null,
      "map_id": 319476,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Ethanol acts as a <strong>competitive inhibitor </strong>of alcohol dehydrogenase, preventing methanol metabolism.</p><ul><li>Enzyme inhibitors are valuable both in research and therapy.</li><li>Their effectiveness depends on various <strong>molecular interactions</strong> (hydrogen bonds, hydrophobic interactions, electrostatics, van der Waals).</li><li>They can be classified based on <strong>site of action</strong>, chemical modification of enzyme, or kinetic effects.</li><li>Two main kinetic categories:</li></ul><ol><li>Inhibition that can be overcome by raising substrate concentration - <strong>competitive (Option C ruled out) </strong></li><li>Inhibition that cannot be overcome in this way - <strong>noncompetitive</strong></li></ol><p><strong>Competitive Inhibition</strong></p><ul><li><strong>Mimics the substrate</strong> and <strong>binds to the active site</strong>.</li><li>Prevents substrate from binding by occupying its place. <strong>(Option D ruled out) </strong></li><li>Example: Malonate inhibits succinate dehydrogenase by competing with succinate.</li><li>Effects: <strong>Vmax unchanged</strong> (can still be reached if enough substrate is added), while <strong>Km increases</strong> (requires higher substrate concentration). <strong>(Option A ruled out) </strong></li><li><strong>Lineweaver-Burk plots:</strong> slope changes, intercept at 1/Vmax stays the same.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/19E1.png\"><p><strong>Noncompetitive Inhibition</strong></p><ul><li>Inhibitor binds to a<strong> different site</strong> (not the substrate-binding site).</li><li>Can bind enzyme whether or not substrate is already attached.</li><li>Effects: <strong>Vmax decreases </strong>(enzyme efficiency reduced), while Km remains unchanged (substrate affinity unaffected).</li><li>Lineweaver-Burk plots show altered y-intercept but same x-intercept.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/19E2.png\"><p><strong>Irreversible Inhibition</strong></p><ul><li>Inhibitors form covalent bonds or stable chemical modifications of essential residues.</li><li>These <strong>permanently inactivate the enzyme</strong> (enzyme is \"poisoned\").</li><li>Examples include inhibitors that attach to amino acid side chains critical for catalysis or structure.</li></ul><p><strong>Mechanism-Based (Suicide) Inhibition</strong></p><ul><li>Specialized inhibitors resembling substrates.</li><li>Bind to active site, where the enzyme's own catalytic action transforms them into a highly reactive compound.</li><li>This reactive form then covalently attaches to the enzyme, blocking a vital residue.</li><li>They are <strong>highly specific</strong> and only active within the enzyme's catalytic site, making them powerful and selective inhibitors.</li></ul>",
      "correct_choice_id": 182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 20,
      "choices": [
        {
          "id": 191,
          "text": "<p><span style=\"font-size:12.0pt;\">ATP acts as a positive allosteric effector on phosphofructokinase-1 (PFK-1), accelerating glycolysis</span></p>"
        },
        {
          "id": 192,
          "text": "<p><span style=\"font-size:12.0pt;\">ATP activates isocitrate dehydrogenase allosterically to increase flux through the TCA cycle</span></p>"
        },
        {
          "id": 193,
          "text": "<p><span style=\"font-size:12.0pt;\">Fructose-2,6-bisphosphate binds allosterically to phosphofructokinase-1 (PFK-1), enhancing glycolysis</span></p>"
        },
        {
          "id": 194,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucagon stimulates glycogen phosphorylase by phosphorylation, increasing glucose release</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old man runs a marathon after drinking a glucose-rich energy drink. During the final stretch, his muscle cells rapidly shift toward glycolysis to meet energy demands. In this situation, the rate of glycolysis is upregulated because of allosteric modulation of a key regulatory enzyme. Which of the following best explains this regulation?</span></p>",
      "unique_key": "Q319477",
      "question_audio": null,
      "question_video": null,
      "map_id": 319477,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Among the given options, the allosteric modulation which upregulates glycolysis is binding of <strong>fructose-2,6-bisphosphate</strong> <strong>allosterically to PFK-1, enhancing glycolysis. </strong></p><ul><li>Enzyme activity can be regulated quickly by allosteric ligands or covalent modifications, while long-term regulation relies on protein synthesis.</li><li>Allosteric regulation allows rapid adaptation to changes in metabolic demand.</li></ul><p><strong>Allosteric Effectors</strong></p><ul><li>Small molecules that bind <strong>noncovalently</strong> to enzymes, forming enzyme-effector complexes with properties different from the enzyme alone.</li><li>Binding can either increase (activation) or decrease (inhibition) catalytic efficiency.<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/20E.png\"></li><li>May also influence enzyme location, interactions with other proteins, or sensitivity to additional effectors.</li><li>Effectors often include <strong>metabolic intermediates</strong> or <strong>end products </strong>that act as regulatory ligands.</li></ul><p><strong>Properties of Allosteric Effectors</strong></p><ul><li>The term allosteric means <strong>\"occupying another site,\"</strong> distinct from the active site.</li><li>Often <strong>do not resemble</strong> substrates of the enzyme.</li><li>Example: Serine acts as an effector of 3-phosphoglycerate dehydrogenase.</li><li>Allosteric enzymes alter activity by changing <strong>Km</strong> (K-series), <strong>Vmax</strong> (V-series), or <strong>both</strong>.</li></ul><p><strong>Types of Allosteric Effectors</strong></p><ol><li><strong> Feedback Effectors</strong><ul><li>Usually <strong>pathway end products</strong>.</li><li>Inhibit or activate enzymes controlling the<strong> first committed step</strong> of the pathway (feedback inhibition).</li></ul></li><li><strong> Indicator Metabolites</strong><ul><li>Intermediates with broader roles beyond their own pathway.</li><li>Example: Citrate activates acetyl-CoA carboxylase in fatty acid synthesis; alanine inhibits pyruvate kinase.</li></ul></li><li><strong> Second Messengers</strong><ul><li>Special effectors triggered by external signals like hormones or nerve impulses.</li><li>Examples: cAMP, cGMP, nitric oxide, Ca&#178;&#8314;, inositol phosphates.</li><li>Regulate enzymes involved in processes such as muscle contraction and glycogen breakdown.</li></ul></li></ol><p><strong>Model Example: Aspartate Transcarbamoylase (ATCase)</strong></p><ul><li>Key enzyme in <strong>pyrimidine biosynthesis</strong>.</li><li>Inhibited by <strong>CTP</strong> (end product, feedback inhibition).</li><li>Stimulated by<strong> ATP</strong> (indicator metabolite, balances purine and pyrimidine synthesis).</li></ul><p><strong>Phosphofructokinase-1 (PFK-1) Regulation</strong></p><p><strong>Activators (&#8593; activity)</strong></p><ul><li><strong>Fructose 2,6-bisphosphate</strong> &#8594; <strong>most potent </strong>activator in liver, relieves ATP inhibition.</li><li>Fructose 6-phosphate &#8594; substrate-level activation.</li><li>AMP (5&prime;-AMP)** &#8594; signals low energy, stimulates PFK-1.</li><li>Inorganic phosphate (Pi) &#8594; supports glycolysis.</li><li>Insulin &#8594; increases expression and<strong> activity of PFK-1</strong> in fed state.</li></ul><p><strong>Inhibitors (&#8595; activity)</strong></p><ul><li><strong>ATP</strong> &#8594; high energy charge suppresses enzyme activity.</li><li><strong>Citrate</strong> &#8594; signals abundance of biosynthetic precursors (link with TCA cycle).</li><li><strong>Glucagon</strong> &#8594; lowers fructose 2,6-bisphosphate via cAMP &#8594; inhibits PFK-1.</li><li><strong>H+ ions (low pH, e.g., during lactic acidosis)</strong> &#8594; prevent excess glycolysis.</li></ul><p><strong>Hormonal Regulation</strong></p><ul><li><strong>Insulin (fed state): </strong>&#8593; fructose 2,6-bisphosphate &#8594; activates PFK-1.</li><li>Glucagon (fasting state): &#8595; fructose 2,6-bisphosphate &#8594; inhibits PFK-1, favoring gluconeogenesis.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>ATP acts as a positive allosteric effector on phosphofructokinase-1 (PFK-1), accelerating glycolysis (Option A):</strong> This is wrong since <strong>ATP as an allosteric inhibitor</strong> of PFK-1.</p><p><strong>ATP activates isocitrate dehydrogenase allosterically to increase flux through the TCA cycle (Option B): </strong>This is a false statement as <strong>ATP inhibits</strong> isocitrate dehydrogenase allosterically.</p><p><strong>Glucagon stimulates glycogen phosphorylase by phosphorylation, increasing glucose release (Option D): </strong>This is a true statement related to glycogen breakdown but an example of <strong>covalent modification</strong>.</p>",
      "correct_choice_id": 193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 21,
      "choices": [
        {
          "id": 201,
          "text": "<p><span style=\"font-size:12.0pt;\">It increases enzyme affinity for glucose, making the reaction faster at low substrate concentrations</span></p>"
        },
        {
          "id": 202,
          "text": "<p><span style=\"font-size:12.0pt;\">It decreases enzyme affinity for glucose, requiring a higher substrate concentration to reach half of Vmax</span></p>"
        },
        {
          "id": 203,
          "text": "<p><span style=\"font-size:12.0pt;\">It functions as a non-competitive inhibitor</span></p>"
        },
        {
          "id": 204,
          "text": "<p><span style=\"font-size:12.0pt;\">None of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old researcher is studying the effect of a new antidiabetic drug on hepatic glucokinase activity. In the presence of the drug, the enzyme's Vmax remains unchanged, but the Km for glucose increases twofold. According to the Michaelis-Menten equation, which of the following best describes the drug's action?</span></p>",
      "unique_key": "Q319478",
      "question_audio": null,
      "question_video": null,
      "map_id": 319478,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>According to the Michaelis-Menten equation, the given drug <strong>decreases enzyme affinity for glucose, requiring a higher substrate concentration to reach half of Vmax</strong></p><p><strong>Michaelis-Menten Equation</strong></p><p>Describes how initial reaction velocity (vi) depends on substrate concentration [S].</p><p>Formula: vi = (Vmax [S]) / (Km + [S])</p><p>Km = substrate concentration at which velocity is half of Vmax</p><p>Higher Km &#8594; lower affinity (need more substrate to achieve same rate). <strong>(Option A ruled out) </strong></p><p>In this case, the Km is increasing and Vmax is unchanged, suggestive of competitive inhibition. <strong>(Option C ruled out) </strong></p><p>Key situations:</p><ol><li>When [S] &lt; Km &#8594; velocity is directly proportional to [S].</li><li>When [S] &gt; Km &#8594; velocity approaches Vmax and is independent of [S].</li><li>When [S] = Km &#8594; velocity = &frac12; Vmax.</li></ol><p><strong>Linear Transformation (Lineweaver-Burk Plot)</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/21E.png\"><ul><li>Direct measurement of Vmax and Km is difficult at saturating [S].</li><li>Rearranging the equation gives a linear form: 1/vi = (Km/Vmax)(1/[S]) + 1/Vmax</li><li>This is plotted as 1/vi (y-axis) vs 1/[S] (x-axis).</li></ul><ul><li>Y-intercept = 1/Vmax</li><li>X-intercept = -1/Km</li><li>Slope = Km/Vmax</li></ul>",
      "correct_choice_id": 202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 22,
      "choices": [
        {
          "id": 211,
          "text": "<p><span style=\"font-size:12.0pt;\">Allosteric activation of glycogen phosphorylase by AMP</span></p>"
        },
        {
          "id": 212,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphorylation of glycogen phosphorylase kinase, which in turn phosphorylates and activates glycogen phosphorylase</span></p>"
        },
        {
          "id": 213,
          "text": "<p><span style=\"font-size:12.0pt;\">Dephosphorylation of glycogen synthase, leading to increased glycogenolysis</span></p>"
        },
        {
          "id": 214,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct proteolytic cleavage of glycogen phosphorylase into its active form</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old man is brought to the ER after a road traffic accident. He has severe blood loss and develops hypoglycemia. In response to the stress, epinephrine is released, leading to rapid mobilization of glucose from liver glycogen stores. Which of the following best explains the molecular mechanism by which epinephrine increases hepatic glycogen breakdown in this situation?</span></p>",
      "unique_key": "Q319479",
      "question_audio": null,
      "question_video": null,
      "map_id": 319479,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The molecular mechanism by which epinephrine increases hepatic glycogen breakdown in this scenario is by <strong>phosphorylation of glycogen phosphorylase kinase, which in turn phosphorylates and activates glycogen phosphorylase. </strong>This is an example of <strong>covalent modification</strong>.</p><p><strong>Covalent Modifications</strong></p><ul><li>Proteins can undergo many covalent modifications such as prenylation, glycosylation, hydroxylation, and fatty acylation, which provide unique structural features that last for the protein's lifetime.</li><li>The principle is that <strong>adding or removing a covalent bond</strong> alters the protein's properties, allowing regulation of function.</li><li>Covalent modifications are of two types - irreversible and reversible.</li></ul><p><strong>Irreversible Modifications</strong></p><ul><li><strong>Partial proteolysis of precursor proteins </strong>(proproteins or zymogens) activates them permanently.</li><li>Once cleaved, the protein cannot revert to its inactive form.</li><li>Example: chymotrypsinogen &#8594; chymotrypsin via <strong>hydrolysis of peptide bonds</strong>.</li><li>Many digestive enzymes (trypsin, chymotrypsin, lipases, pepsin) and proteins in blood clotting and <strong>complement cascades </strong>are activated this way.</li></ul><p><strong>Reversible Modifications</strong></p><ul><li>Include acetylation, ADP-ribosylation, sumoylation, and phosphorylation.</li><li>\"Reversible\" refers to the ability to restore the protein to its precursor form by removing the modification.</li></ul><p><strong>Phosphorylation:</strong></p><ul><li>Involves serine, threonine, or tyrosine residues.</li><li><strong>Protein kinases</strong> transfer phosphate groups from ATP.</li><li><strong>Protein phosphatases </strong>remove phosphate groups. (dephosphorylation)</li><li>Phosphorylation changes enzyme activity by altering conformation and function.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/22E1.png\"><br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/22E2.png\"><p><strong>Protein Acetylation</strong></p><ul><li>Involves adding an acetyl group to lysine residues.</li><li>Can directly regulate mitochondrial proteins by responding to acetyl-CoA levels.</li><li>Requires acetyltransferases and is reversed by deacetylases (histone deacetylases and sirtuins).</li><li>Acts as a sensor of <strong>cell energy state: </strong>high acetyl-CoA &#8594; increased acetylation; low acetyl-CoA &#8594; favors deacetylation.</li></ul><p><strong>Covalent Modifications and Metabolism</strong></p><ul><li>Phosphorylation and acetylation are powerful regulators of metabolic enzymes.</li><li>They function like allosteric control but work through covalent bond changes.</li><li>Allow rapid, specific adjustments of enzyme activity in response to metabolic needs.</li><li>Example enzymes regulated by phosphorylation include: acetyl-CoA carboxylase, glycogen synthase, pyruvate dehydrogenase, HMG-CoA reductase, glycogen phosphorylase, and citrate lyase.</li></ul><p><strong>Key Point</strong></p><ul><li>Reversible covalent modifications (phosphorylation, acetylation) provide flexibility and rapid adaptation.</li><li>Irreversible modifications (proteolysis) ensure <strong>permanent activation of enzymes</strong> when required, such as in digestion, blood clotting, and immune defense.</li></ul><p><strong>Explanations of other options:</strong></p><p><strong>Allosteric AMP activation (Option A): </strong>True for glycogen phosphorylase in muscle, but here the vignette is about hormonal regulation in liver.</p><p><strong>Dephosphorylation of glycogen synthase (Option C): Activates glycogen synthesis</strong>, not breakdown.</p><p><strong>Proteolytic cleavage (Option D): Selective proteolysis </strong>is seen in<strong> trypsinogen &#8594; trypsin, </strong>for example and is not relevant to glycogen phosphorylase.</p>",
      "correct_choice_id": 212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 23,
      "choices": [
        {
          "id": 221,
          "text": "<p><span style=\"font-size:12.0pt;\">Sigmoid curve</span></p>"
        },
        {
          "id": 222,
          "text": "<p><span style=\"font-size:12.0pt;\">Bell-shaped curve</span></p>"
        },
        {
          "id": 223,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperbolic curve</span></p>"
        },
        {
          "id": 224,
          "text": "<p><span style=\"font-size:12.0pt;\">Linear curve</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">When enzyme activity is plotted against varying pH values, which type of curve is typically observed?</span></p>",
      "unique_key": "Q319480",
      "question_audio": null,
      "question_video": null,
      "map_id": 319480,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Enzyme activity rises as pH approaches the optimum, then declines on either side when ionization of active site residues and substrates is altered, which produces a <strong>bell-shaped curve</strong>, with the peak at the enzyme's optimal pH.</p><p><strong>Enzyme Catalysis</strong></p><ul><li>Enzymes<strong> lower the activation energy (&Delta;G&Dagger;)</strong>, stabilizing transition states and thereby speeding up reactions.</li><li>Some use unique mechanisms, such as covalent catalysis, to form temporary enzyme-substrate bonds.</li></ul><p><strong>Equilibrium Constant (Keq)</strong></p><ul><li>At equilibrium, the rate of forward and reverse reactions becomes equal.</li><li>The <strong>equilibrium constant</strong> is defined as the ratio of the rate constants of the forward and reverse reactions.</li><li>Importantly, equilibrium represents a dynamic state, where reactants and products are <strong>constantly interconverted</strong> without net change.</li></ul><p><strong>Enzymes and Keq: </strong>Although enzymes alter reaction speed, they do not change the equilibrium constant (Keq) or the overall free energy difference (&Delta;G&deg;). They only affect how quickly equilibrium is reached.</p><p><strong>Temperature and Enzymes</strong></p><ul><li>Both uncatalyzed and enzyme-catalyzed reactions increase with temperature. However, excessive heat can disrupt noncovalent interactions, leading to<strong> denaturation</strong> and loss of function.</li><li>The <strong>temperature coefficient (Q10)</strong> describes the rate increase for a 10&deg;C rise in temperature.</li></ul><p><strong>pH</strong></p><ul><li>Enzyme activity is strongly influenced by hydrogen ion concentration. Most enzymes function best in a <strong>specific pH range</strong>, and deviation can disrupt the charge states of amino acids involved in substrate binding or catalysis.</li><li>This alters enzyme activity, sometimes abolishing it completely.</li><li>The majority of intracellular enzymes function best within a pH range of 5 to 9, forming a bell-shaped curve as shown below.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/23E.png\"><p><strong>Substrate Concentration</strong></p><ul><li>Reaction velocity<strong> initially rises with substrate concentration</strong> but <strong>eventually plateaus </strong>at Vmax when all enzyme molecules are saturated with substrate.</li><li>At this stage, the rate depends only on how quickly the enzyme releases the product so it can bind new substrate.</li></ul>",
      "correct_choice_id": 222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 24,
      "choices": [
        {
          "id": 231,
          "text": "<p><span style=\"font-size:12.0pt;\">Km increases while Vmax remains unchanged</span></p>"
        },
        {
          "id": 232,
          "text": "<p><span style=\"font-size:12.0pt;\">Km decreases while Vmax increases</span></p>"
        },
        {
          "id": 233,
          "text": "<p><span style=\"font-size:12.0pt;\">Km remains unchanged while Vmax decreases</span></p>"
        },
        {
          "id": 234,
          "text": "<p><span style=\"font-size:12.0pt;\">The inhibitor structurally resembles the substrate and binds at the active site</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the type of enzyme inhibition depicted in the Lineweaver-Burk plot?<br><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/24Q.png\"></span></p>",
      "unique_key": "Q319481",
      "question_audio": null,
      "question_video": null,
      "map_id": 319481,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The type of enzyme inhibition depicted is non-competitive inhibition (altered y-intercept but same x-intercept) and the true statement regarding <strong>non-competitive inhibition</strong> is <strong>Km remains unchanged while Vmax decreases</strong>.</p><ul><li>In non-competitive inhibition, the inhibitor binds to an enzyme at a <strong>site distinct from the substrate-binding site </strong>and usually have no structural resemblance to the substrate. <strong>(Option D ruled out)</strong></li><li>This binding does not interfere with substrate attachment, so both enzyme-substrate (ES) and enzyme-inhibitor (EI) complexes can form.</li><li>However, when the inhibitor is bound, the enzyme's ability to convert substrate into product is reduced, leading to a <strong>decrease in Vmax, while Km remains unchange</strong>d in simple non-competitive inhibition. <strong>(Options A and B ruled out) </strong></li><li>Both the free enzyme (E) and the enzyme-inhibitor complex (EI) have <strong>equal affinity</strong> for the substrate, but the enzyme-inhibitor-substrate (EIS) complex produces little to no product.</li><li>In more complex forms of non-competitive inhibition, the inhibitor may alter the enzyme's apparent affinity for the substrate, modifying Km as well.</li><li>Lineweaver-Burk plots show <strong>altered y-intercept </strong>but same x-intercept.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/24E.png\">",
      "correct_choice_id": 233,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 25,
      "choices": [
        {
          "id": 241,
          "text": "<p><span style=\"font-size:12.0pt;\">The mutant enzyme has greater turnover</span></p>"
        },
        {
          "id": 242,
          "text": "<p><span style=\"font-size:12.0pt;\">The mutant enzyme has lower affinity but still higher catalytic efficiency</span></p>"
        },
        {
          "id": 243,
          "text": "<p><span style=\"font-size:12.0pt;\">The mutant enzyme has higher efficiency and higher affinity</span></p>"
        },
        {
          "id": 244,
          "text": "<p><span style=\"font-size:12.0pt;\">Both the enzymes have similar catalytic efficiency</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 35-year-old man with chronic kidney disease is enrolled in a clinical trial testing a new isoform of urease enzyme for use in hemodialysis patients. Researchers compare its kinetics with the normal enzyme:<br><br>.Normal urease: Km = 2 mM, kcat = 400 s&#8315;&#185;<br>Mutant urease: Km = 0.5 mM, kcat = 100 s&#8315;&#185;<br><br>Which of the following statements regarding the catalytic efficiency (kcat/Km) of the mutant enzyme is correct?</span></p>",
      "unique_key": "Q319482",
      "question_audio": null,
      "question_video": null,
      "map_id": 319482,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Both the enzymes have similar catalytic efficiency</p><p><strong>Catalytic Constant (kcat)</strong></p><ul><li>Used to describe the activity of a pure enzyme preparation.</li><li>Also called the<strong> turnover number:</strong> how many substrate molecules are converted to product per unit time by one active site of the enzyme.<strong> (Option A ruled out) </strong></li><li><strong>Formula:</strong><ul><li>kcat = Vmax / [E]t, where [E]t is the total concentration of enzyme active sites.</li><li>Units: reciprocal time (e.g., s&#8315;&#185;).</li></ul></li></ul><p><strong>Catalytic Efficiency (kcat/Km)</strong></p><ul><li>Reflects how effectively an enzyme converts substrate to product.</li><li>Accounts for both kcat (maximum capacity of the enzyme) and Km (substrate affinity).</li><li>Km = substrate concentration at which velocity is half of Vmax</li><li>Higher Km &rarr; lower affinity (need more substrate to achieve same rate).<strong> (Option B ruled out) </strong></li><li>A high kcat alone is not sufficient; efficiency also requires a low Km, meaning the enzyme works effectively even at low substrate concentrations.</li><li>Therefore, kcat/Km is the best measure of enzyme efficiency and allows comparison of: Different enzymes, different substrates for the same enzyme, and forward vs reverse catalytic activity.</li></ul><p>Catalytic efficiency of normal urease = 400/2 = 200 s&#8315;&#185; mM&#8315;&#185;</p><p>Catalytic efficiency of mutant urease = 100/0.5 = 200 s&#8315;&#185; mM&#8315;&#185;</p><p>Both the enzymes have the same catalytic efficiency<strong> (Option C ruled out) </strong></p>",
      "correct_choice_id": 244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 26,
      "choices": [
        {
          "id": 251,
          "text": "<p><span style=\"font-size:12.0pt;\">1 ATP, 1 NADH, 2 FADH&#8322;</span></p>"
        },
        {
          "id": 252,
          "text": "<p><span style=\"font-size:12.0pt;\">1 GTP, 3 NADH, 1 FADH&#8322;</span></p>"
        },
        {
          "id": 253,
          "text": "<p><span style=\"font-size:12.0pt;\">2 GTP, 2 NADH, 2 FADH&#8322;</span></p>"
        },
        {
          "id": 254,
          "text": "<p><span style=\"font-size:12.0pt;\">1 ATP, 2 NADH, 1 FADH&#8322;</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 56-year-old man with chronic alcoholism presents with weakness and shortness of breath. Labs reveal lactic acidosis and thiamine deficiency. His physician explains that due to impaired activity of pyruvate dehydrogenase and &alpha;-ketoglutarate dehydrogenase, his ATP production from the Krebs cycle is significantly reduced. Under normal conditions, complete oxidation of one molecule of acetyl-CoA in the Krebs cycle generates which of the following energy equivalents (before accounting for oxidative phosphorylation of NADH and FADH&#8322;)?</span></p>",
      "unique_key": "Q319483",
      "question_audio": null,
      "question_video": null,
      "map_id": 319483,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Under normal conditions, complete oxidation of one molecule of acetyl-CoA in the Krebs cycle generates <strong>1 GTP, 3 NADH, 1 FADH&#8322; </strong>before accounting for oxidative phosphorylation of NADH and FADH&#8322;.</p><p><strong>Citric Acid Cycle</strong></p><p><strong>Biomedical importance:</strong></p><ul><li>The <strong>citric acid cycle (Krebs or tricarboxylic acid cycle)</strong> occurs in<strong> mitochondria</strong> and is the final pathway for <strong>oxidizing</strong> carbohydrates, fats, and proteins.</li><li><strong>Acetyl-CoA</strong> from glucose, fatty acids, or amino acids enters the cycle, producing CO&#8322;, and reducing equivalents (NADH, FADH&#8322;) and ATP.</li><li>It also supports gluconeogenesis, lipogenesis, and amino acid interconversions. Since the liver is central to these processes, damage such as hepatitis or cirrhosis disrupts the cycle.</li><li>Disorders like <strong>hyperammonemia</strong> impair the cycle by <strong>depleting &alpha;-ketoglutarate</strong> and blocking ATP formation, leading to neurological problems.</li></ul><p><strong>Link to respiratory chain:</strong></p><ul><li>The cycle starts when <strong>acetyl-CoA</strong> combines with <strong>oxaloacetate </strong>to form citrate. T</li><li>hrough successive steps, two molecules of CO&#8322; are released, and oxaloacetate is regenerated, allowing the cycle to continue.</li><li>Enzymes are located in the <strong>mitochondrial matrix and inner membrane</strong>. The reduced coenzymes produced feed into the <strong>electron transport chain</strong> to generate ATP.</li></ul><p><strong>Key reactions and enzymes:</strong></p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/26E.png\"><ol><li><strong>Citrate synthase:</strong> acetyl-CoA + oxaloacetate &rarr; citrate.</li><li><strong>Aconitase:</strong> citrate &harr; isocitrate.</li><li><strong>Isocitrate dehydrogenase:</strong> isocitrate &rarr; &alpha;-ketoglutarate (releases CO&#8322;, <strong>NADH</strong>).</li><li><strong>&alpha;-Ketoglutarate dehydrogenase complex:</strong> &alpha;-ketoglutarate &rarr; succinyl-CoA (releases CO&#8322;, <strong>NADH</strong>).<ul><li>Requires thiamine, lipoate, NAD&#8314;, FAD, and CoA.</li><li>Inhibited by arsenite and high ammonia.</li></ul></li><li><strong>Succinyl-CoA synthetase (thiokinase):</strong> succinyl-CoA &rarr; succinate (produces <strong>GTP/ATP</strong>).</li><li><strong> Succinate dehydrogenase:</strong> succinate &rarr; fumarate (produces <strong>FADH&#8322;</strong>).<ul><li>Bound to the mitochondrial membrane, part of respiratory chain.</li></ul></li><li><strong>Fumarase:</strong> fumarate &rarr; malate.</li><li><strong>Malate dehydrogenase:</strong> malate &rarr; oxaloacetate (produces <strong>NADH</strong>).</li></ol><p><strong>Energy yield per cycle (one acetyl-CoA):</strong></p><ul><li>3 NADH &rarr; ~7.5 ATP (2.5 ATP per NADH)</li><li>1 FADH&#8322; &rarr; ~1.5 ATP</li><li>1 GTP (or ATP) &rarr; 1 ATP</li><li>Total: ~10 ATP per turn.</li></ul><p><strong>Special points:</strong></p><ul><li><strong>Anaplerosis:</strong> replenishment of intermediates (e.g., pyruvate &rarr; oxaloacetate).</li><li><strong>Cataplerosis: </strong>withdrawal of intermediates (e.g., citrate export for fatty acid synthesis</li></ul>",
      "correct_choice_id": 252,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 27,
      "choices": [
        {
          "id": 261,
          "text": "<p><span style=\"font-size:12.0pt;\">Stops proton pumping at Complex IV, collapsing the proton gradient and abolishing ATP synthesis</span></p>"
        },
        {
          "id": 262,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduces ATP yield by blocking Complex I</span></p>"
        },
        {
          "id": 263,
          "text": "<p><span style=\"font-size:12.0pt;\">Allows continued proton pumping but prevents ATP synthase from utilizing the gradient</span></p>"
        },
        {
          "id": 264,
          "text": "<p><span style=\"font-size:12.0pt;\">Increases oxygen consumption but decreases ATP yield due to uncoupling of oxidation and phosphorylation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old laboratory worker collapses after inhaling fumes during a chemical accident. He is found to have lactic acidosis and bright red venous blood. Cyanide poisoning is suspected. From a bioenergetics perspective, which of the following best describes the effect of cyanide on mitochondrial oxidative phosphorylation?</span></p>",
      "unique_key": "Q319484",
      "question_audio": null,
      "question_video": null,
      "map_id": 319484,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p><strong>Cyanide</strong> stops<strong> proton pumping at Complex IV, </strong>collapsing the <strong>proton gradient </strong>and <strong>abolishing ATP synthesis. </strong></p><p><strong>Respiratory Chain &amp; Oxidative Phosphorylation</strong></p><p><strong>Biomedical Importance</strong></p><ul><li>Mitochondria are the key sites for respiration, producing <strong>ATP</strong> through <strong>oxidative phosphorylation</strong>.</li><li>Inhibitors such as cyanide and carbon monoxide can block this process, leading to severe consequences like<strong> lactic acidosis</strong>, encephalopathy, and myopathy.</li></ul><p><strong>Compartmentalization of Enzymes</strong></p><ul><li>The mitochondrion has a double membrane. The outer membrane is permeable to many metabolites, while the<strong> inner membrane</strong> is <strong>highly selective</strong> and hosts critical enzymes such as acyl-CoA synthetase and glycerol phosphate acyltransferase.</li><li>The inner membrane also contains the respiratory chain, <strong>ATP synthase</strong>, and transport proteins.</li></ul><p><strong>Respiratory Chain Function</strong></p><ul><li>The respiratory chain captures electrons from carbohydrate, fat, and protein oxidation, transferring them through complexes I-IV embedded in the inner membrane.</li><li>This process reduces oxygen to water and traps energy in ATP.</li></ul><p><strong>Electron Transfer Components</strong></p><ul><li>The following diagram illustrates how electrons move through the respiratory chain complexes, highlighting where reducing equivalents from key substrates enter.</li><li>Coenzyme Q (ubiquinone) and cytochrome c serve as<strong> mobile carriers</strong> within the system.</li><li>(Abbreviations: cyt = cytochrome, ETF = electron-transferring flavoprotein, Fe-S = iron-sulfur protein, Q = coenzyme Q/ubiquinone).<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/27E.png\"></li><li>Flavoproteins (FMN, FAD) and iron-sulfur proteins (Fe-S) are key electron carriers.</li><li>Coenzyme Q (ubiquinone) shuttles electrons between complexes.</li><li>Cytochromes (b, c1, c, a, a3) carry electrons through <strong>redox reactions</strong>.</li><li>Complex IV <strong>reduces O&#8322; to H&#8322;O,</strong> tightly controlling the reaction to minimize harmful intermediates.</li></ul><p><strong>Proton Gradient &amp; ATP Formation</strong></p><ul><li>As electrons pass through the chain, protons are pumped across the inner mitochondrial membrane (Complexes I, III, IV).</li><li>This generates the <strong>proton motive force</strong>, which powers ATP synthesis via ATP synthase (F&#8320;F&#8321; complex).</li><li>The rotary mechanism of <strong>ATP synthase </strong>couples proton flow to ATP formation through conformational changes in its &beta;-subunits.</li></ul><p><strong>Energy Yield</strong></p><ul><li>For each NADH oxidized, about 2.5 ATP are produced.</li><li>For FADH&#8322;, about 1.5 ATP are produced.</li><li>Including substrate-level phosphorylation, nearly 90% of cellular ATP comes from oxidative phosphorylation.</li></ul><p><strong>Inhibitors &amp; Poisons</strong></p><ul><li><strong>Complex I inhibitors:</strong> Barbiturates (e.g., amobarbital), rotenone</li><li><strong>Complex II inhibitors:</strong> Malonate (competitive).</li><li><strong>Complex III inhibitors: </strong>Antimycin A, dimercaprol.</li><li><strong>Complex IV inhibitors: </strong>H&#8322;S, cyanide, CO.</li><li><strong>ATP synthase inhibitors:</strong></li><li><strong>Uncouplers (e.g., 2,4-DNP, thermogenin):</strong> Increase proton leak, causing heat generation instead of ATP.</li></ul><p><strong>Chemiosmotic Theory</strong></p><ul><li>Explains how proton translocation across the membrane creates an electrochemical gradient that drives ATP synthesis.</li><li><strong>Uncouplers</strong> disrupt this gradient, allowing oxidation <strong>without ATP production</strong>.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Reduces ATP yield by blocking Complex I (Option B): </strong>Describes complex I inhibitors such as <strong>amobarbital</strong>.</p><p><strong>Allows continued proton pumping but prevents ATP synthase from utilizing the gradient (Option C): </strong>Describes ATP synthase inhibitors such as <strong>oligomycin</strong>.</p><p><strong>Increases oxygen consumption but decreases ATP yield due to uncoupling of oxidation and phosphorylation (Option D): </strong>Describes uncouplers such as <strong>dinitrophenol</strong>.</p>",
      "correct_choice_id": 261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 28,
      "choices": [
        {
          "id": 271,
          "text": "<p><span style=\"font-size:12.0pt;\">Failure of carnitine-mediated transport of fatty acids into mitochondria</span></p>"
        },
        {
          "id": 272,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct inhibition of ATP synthase, preventing proton-driven ATP generation</span></p>"
        },
        {
          "id": 273,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased acetyl-CoA supply limits both the TCA cycle and ketone body formation</span></p>"
        },
        {
          "id": 274,
          "text": "<p><span style=\"font-size:12.0pt;\">Reduced NADH and FADH&#8322; production from fatty acid oxidation, leading to impaired oxidative phosphorylation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy is brought with recurrent episodes of vomiting, lethargy, and seizures, especially after overnight fasting. During one episode, his labs show hypoglycemia, very low ketone bodies, and elevated dicarboxylic acids in urine. From a bioenergetics perspective, which of the following best explains why this child cannot maintain adequate ATP levels during fasting?</span></p>",
      "unique_key": "Q319485",
      "question_audio": null,
      "question_video": null,
      "map_id": 319485,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The most probable diagnosis based on the clinical features of hypoglycemia, hypoketosis, and elevated dicarboxylic acids in urine is medium chain fatty Acyl-CoA dehydrogenase deficiency which is an inherited disorder of <strong>&beta;-Oxidation of Fatty Acids </strong>which leads to <strong>reduced NADH and FADH&#8322; production from fatty acid oxidation, leading to impaired oxidative phosphorylation.</strong></p><p><strong>&beta;-Oxidation of Fatty Acids</strong></p><p>&beta;-oxidation occurs in cycles of four steps targeting the &beta;-carbon (third carbon).</p><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/28E.png\"><p>The sequence involves:</p><ol><li><strong>Oxidation</strong> - produces FADH&#8322;.</li><li><strong>Hydration</strong></li><li><strong>Second oxidation </strong>- produces NADH.</li><li><strong>Thiolytic cleavage</strong> - releases acetyl-CoA.<ul><li>Each cycle shortens the fatty acid chain by two carbons and generates one acetyl-CoA, one NADH, and one FADH&#8322;.</li><li>The process repeats until the entire fatty acid is degraded; the final round yields two acetyl-CoA molecules.</li><li><strong>Reduced coenzymes (NADH, FADH&#8322;)</strong> enter the electron transport chain for <strong>ATP generation</strong>.</li><li>Acetyl-CoA acts as a positive regulator of pyruvate carboxylase,<strong> linking fatty acid breakdown with gluconeogenesis.</strong></li></ul></li></ol><p><strong>Medium-Chain Fatty Acyl-CoA Dehydrogenase (MCAD) Deficiency</strong></p><ul><li>Mitochondria contain four types of acyl-CoA dehydrogenases, each specialized for short-, medium-, long-, or very-long-chain fatty acids.</li><li>MCAD deficiency is the <strong>most common inherited disorder of &beta;-oxidation</strong>.</li><li>Inheritance: <strong>Autosomal recessive </strong></li><li>Defective oxidation of 6-10 carbon fatty acids leads to:<ul><li><strong>Reduced acetyl-CoA </strong> <strong>(Option C ruled out) </strong></li><li>Increased dependence on glucose for energy.</li><li><strong>Hypoketotic hypoglycemia</strong> during fasting or illness.</li></ul></li><li>Clinical findings: accumulation of medium-chain acylcarnitines and <strong>dicarboxylic acids in urine</strong>.</li><li>Management: avoidance of fasting to prevent metabolic crises.</li></ul><p><strong>Explanation of other options:</strong></p><p><strong>Failure of carnitine-mediated transport of fatty acids into mitochondria (Option A): </strong>Describes primary carnitine deficiency or CPT-I deficiency, not MCAD</p><p><strong>Direct inhibition of ATP synthase, preventing proton-driven ATP generation (Option B): </strong>Describes oligomycin, not MCAD.</p>",
      "correct_choice_id": 274,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 29,
      "choices": [
        {
          "id": 281,
          "text": "<p><span style=\"font-size:12.0pt;\">4 ATP</span></p>"
        },
        {
          "id": 282,
          "text": "<p><span style=\"font-size:12.0pt;\">2 ATP</span></p>"
        },
        {
          "id": 283,
          "text": "<p><span style=\"font-size:12.0pt;\">6 ATP</span></p>"
        },
        {
          "id": 284,
          "text": "<p><span style=\"font-size:12.0pt;\">8 ATP</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 24-year-old marathon runner collapses at the finish line. He is dehydrated, tachycardic, and has lactic acidosis. His physician explains that during prolonged oxygen deprivation in exercising muscle, ATP production shifts entirely to anaerobic glycolysis. From one molecule of glucose under these anaerobic conditions, how many net ATP molecules are generated in skeletal muscle?</span></p>",
      "unique_key": "Q319486",
      "question_audio": null,
      "question_video": null,
      "map_id": 319486,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>Under <strong>anaerobic conditions</strong>, the net ATP molecules generated from one molecule of glucose in skeletal muscle is <strong>2 ATP</strong>.</p><p><strong>Biomedical Importance of Glycolysis</strong></p><ul><li><strong>Glucose </strong>is a vital fuel for nearly all tissues, with the <strong>brain </strong>heavily dependent on it except during prolonged fasting when ketones take over partially.</li><li><strong>Glycolysis</strong>, occurring in the <strong>cytosol</strong>, is the central pathway for glucose and carbohydrate breakdown. It operates both in the presence and absence of oxygen.</li><li><strong>Red blood cells</strong> rely solely on <strong>anaerobic glycolysis</strong> since they lack mitochondria.</li><li>Anaerobic glycolysis allows skeletal muscle to generate energy during<strong> intense activity </strong>when oxygen supply is limited, helping tissues withstand oxygen shortage.</li><li>In contrast, cardiac muscle has lower glycolytic activity, making it more vulnerable under ischemic conditions.</li><li>The steps of glycolysis are shown below.<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/29E.png\"></li></ul><p><strong>Glycolysis in Anaerobic Conditions</strong></p><ul><li>Anaerobic glycolysis resembles fermentation and is observed in contracting muscle when oxygen is scarce.</li><li>Under these conditions, glycogen is broken down, lactate accumulates, and ATP continues to be produced without mitochondrial involvement.</li><li>When oxygen returns, lactate production halts as pyruvate and NADH are oxidized in the mitochondria.</li><li>In low oxygen, <strong>NADH cannot be reoxidized</strong> through the electron transport chain, and <strong>pyruvate accepts electrons and is reduced to lactate</strong>. This maintains NAD&#8314; supply, allowing glycolysis to persist.</li><li>However, anaerobic glycolysis is less efficient, generating <strong>far less ATP per glucose </strong>molecule (2 ATP) compared to aerobic metabolism, requiring higher glucose consumption to meet energy needs. <strong>(Options A, C, and D ruled out) </strong></li><li>In yeast and some microbes, anaerobic glycolysis leads not to lactate but to <strong>ethanol production</strong> through decarboxylation and reduction steps.</li></ul><img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/29E1.png\">",
      "correct_choice_id": 282,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 30,
      "choices": [
        {
          "id": 291,
          "text": "<p><span style=\"font-size:12.0pt;\">Low serum ceruloplasmin -increased urinary copper -decreased serum copper</span></p>"
        },
        {
          "id": 292,
          "text": "<p><span style=\"font-size:12.0pt;\">Low serum copper with low ceruloplasmin and normal urinary copper excretion</span></p>"
        },
        {
          "id": 293,
          "text": "<p><span style=\"font-size:12.0pt;\">Undetectable ceruloplasmin with markedly low serum copper and iron accumulation</span></p>"
        },
        {
          "id": 294,
          "text": "<p><span style=\"font-size:12.0pt;\">Elevated serum ceruloplasmin with reduced urinary copper</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old boy is brought with behavioral changes, difficulty speaking, and tremors. On examination, he has hepatosplenomegaly and mild jaundice. Ophthalmologic exam shows a brownish ring at the corneal margin. Which of the following laboratory findings is most consistent with this condition?</span></p>",
      "unique_key": "Q319487",
      "question_audio": null,
      "question_video": null,
      "map_id": 319487,
      "difficulty_level": "intermediate",
      "subjects_id": [
        1000186
      ],
      "solution": "<p><strong>Explanation:</strong></p><p>The most likely diagnosis based on the given clinical features is Wilson's disease and among the given options, <strong>low serum ceruloplasmin - increased urinary copper - decreased serum copper </strong>is consistent with this condition.</p><p><strong>Wilson's disease </strong></p><ul><li>An autosomal recessive disorder caused by defective copper transport due to mutations in ATP7B.</li><li>Leads to copper accumulation in the liver, brain, eyes, and other organs.</li></ul><p><strong>Clinical Phenotypes</strong></p><p><strong>Hepatic:</strong></p><ul><li>Jaundice, hepatomegaly, ascites, edema, splenomegaly.</li><li>Cirrhosis and chronic hepatitis common.</li></ul><p><strong>Neurological:</strong></p><ul><li>Dysarthria, dystonia, tremor (wing-beating type), abnormal gait, seizures, parkinsonian features.</li><li>Psychiatric manifestations: irritability, mood changes, poor academic performance, depression, or psychosis.</li></ul><p><strong>Ocular:</strong></p><ul><li>Kayser-Fleischer rings (copper in corneal Descemet's membrane)<img class=\"w-100\" style=\"width:50%;height:auto;display:block;vertical-align: middle;border:0; \"src=\"https://d3fkkq5frqjyl8.cloudfront.net/Quiz2025/NEETPG/QuizOct2025/BiochemSWTI07102025/30E.png\"></li><li>Sunflower cataract.</li></ul><p><strong>Other effects:</strong></p><ul><li>Hemolytic anemia due to copper-induced red cell membrane damage.</li><li>Skeletal abnormalities: osteoporosis, rickets, osteoarthritis.</li><li>Renal issues: aminoaciduria, phosphaturia, nephrolithiasis.</li></ul><p><strong>Biochemical Findings</strong></p><ul><li><strong>Low serum ceruloplasmin</strong> and <strong>reduced total serum copper</strong>.</li><li><strong>Increased urinary copper excretion</strong> (&gt;100 &micro;g/day).<strong> (Option D ruled out) </strong></li><li>High hepatic copper content (&gt;200 &micro;g/g dry weight).</li><li>Radiolabeled copper tests show poor incorporation into ceruloplasmin.</li></ul><p><strong>Molecular Basis</strong></p><ul><li>Caused by loss-of-function mutations in ATP7B, a P-type ATPase responsible for copper excretion into bile and incorporation into ceruloplasmin.</li></ul><p><strong>Diagnosis</strong></p><ul><li>Based on combination of clinical, biochemical, and genetic tests.</li><li>Kayser-Fleischer rings are a key diagnostic sign, especially in neurologic presentations.</li><li>A validated scoring system (Leipzig) integrates clinical, lab, and genetic data.</li></ul><p><strong>Treatment</strong></p><p><strong>Copper Chelation:</strong></p><ul><li><strong>Penicillamine (first-line)</strong> - binds copper for urinary excretion; requires pyridoxine supplementation.</li><li>Trientine - alternative chelator with fewer side effects.</li><li>Tetrathiomolybdate - reduces copper absorption and free copper levels.</li></ul><p><strong>Zinc Therapy:</strong></p><ul><li>Blocks intestinal copper absorption by inducing metallothionein.</li><li>Used in presymptomatic patients, pregnant women, or as maintenance therapy.</li></ul><p><strong>Liver Transplantation:</strong></p><ul><li>Reserved for fulminant hepatic failure or end-stage disease unresponsive to therapy.</li><li>Can correct both hepatic and neurologic symptoms.</li></ul><p><strong>Explanation of other options: </strong></p><p><strong>Low serum copper with low ceruloplasmin and normal urinary copper excretion (Option B):</strong> Describes Menke disease</p><p><strong>Undetectable ceruloplasmin with markedly low serum copper and iron but tissue iron overload (Option C): </strong>Suggestive of aceruloplasminemia.</p>",
      "correct_choice_id": 291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "Factual"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}